British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017

Plain language summary available online

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 177; no. 5; pp. 1170 - 1201
Main Authors Harman, K.E., Brown, D., Exton, L.S., Groves, R.W., Hampton, P.J., Mohd Mustapa, M.F., Setterfield, J.F., Yesudian, P.D.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.11.2017
Subjects
Administration, Cutaneous
Administration, Oral
Adrenal Cortex Hormones - administration & dosage
Aftercare
Autoimmune diseases
Blister - therapy
Chemotherapy, Adjuvant
Child
Clinical Laboratory Techniques - methods
Dermatologic Agents - therapeutic use
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Forecasting
Humans
Immunosorbent Techniques
Immunosuppressive Agents - therapeutic use
Infusions, Intravenous
Nursing Care
Pemphigus
Pemphigus - diagnosis
Pemphigus - therapy
Photopheresis - methods
Plasma Exchange - methods
Plasmapheresis - methods
Pregnancy
Pregnancy Complications - therapy
Refusal to Treat
Remission Induction
Skin diseases
Social Support
Online AccessGet full text
ISSN0007-0963
1365-2133
1365-2133
DOI10.1111/bjd.15930

Cover

Abstract Plain language summary available online
AbstractList Plain language summary available online
Author Harman, K.E.
Yesudian, P.D.
Mohd Mustapa, M.F.
Setterfield, J.F.
Brown, D.
Groves, R.W.
Hampton, P.J.
Exton, L.S.
Author_xml – sequence: 1
  givenname: K.E.
  surname: Harman
  fullname: Harman, K.E.
  email: karenharman@doctors.org.uk, guidelines@bad.org.uk
  organization: Infirmary Square
– sequence: 2
  givenname: D.
  surname: Brown
  fullname: Brown, D.
  organization: Guy's and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital
– sequence: 3
  givenname: L.S.
  surname: Exton
  fullname: Exton, L.S.
  organization: British Association of Dermatologists
– sequence: 4
  givenname: R.W.
  surname: Groves
  fullname: Groves, R.W.
  organization: King's College London
– sequence: 5
  givenname: P.J.
  surname: Hampton
  fullname: Hampton, P.J.
  organization: Royal Victoria Infirmary
– sequence: 6
  givenname: M.F.
  surname: Mohd Mustapa
  fullname: Mohd Mustapa, M.F.
  organization: British Association of Dermatologists
– sequence: 7
  givenname: J.F.
  surname: Setterfield
  fullname: Setterfield, J.F.
  organization: King's College London Dental Institute
– sequence: 8
  givenname: P.D.
  surname: Yesudian
  fullname: Yesudian, P.D.
  organization: Wrexham Maelor Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29192996$$D View this record in MEDLINE/PubMed
BookMark eNp90btOHDEUBmALEYVlk4IXQJZokmLg-DKedcklN4REQ-qR13s869XMeLE9iejyGrweT5JZFiiQwM1pvv_I-s8-2e1Dj4QcMDhm4zuZrxbHrNQCdsiECVUWnAmxSyYAUBWgldgj-ymtAJiAEj6SPa6Z5lqrCTFn0WeflvQ0pWC9yT70NDh6gbEzObSh8Smnh3_3tBn8AlvfY6IuRJqXSDvTmwY77PMmssZuvfTNkOifoW1M9IlyYNUn8sGZNuHnpzklv79_uzn_WVxd__h1fnpVWFlKKAybq5kyyKoSmTAclFxwEHJmnLVzy5QrZ84ZxyuFmgs0IJmUVlfomFFQiin5st27juF2wJTrzieLbWt6DEOqma6YkqUYe5qSo1d0FYbYj7_bKOAglZyN6vBJDfMOF_U6-s7Eu_q5vBF83QIbQ0oR3QthUG8OU4-HqR8PM9qTV9b6_Nh2jsa37yX--hbv3l5dn11ebBP_AV0Pnl0
CitedBy_id crossref_primary_10_1111_dth_13057
crossref_primary_10_1016_j_bjae_2021_05_007
crossref_primary_10_4103_jfmpc_jfmpc_765_19
crossref_primary_10_1111_ajd_12963
crossref_primary_10_1007_s13555_019_00346_x
crossref_primary_10_29176_2590843X_1884
crossref_primary_10_1111_vde_13028
crossref_primary_10_1093_bjd_ljad140
crossref_primary_10_7759_cureus_74511
crossref_primary_10_1016_j_piel_2023_11_010
crossref_primary_10_1111_phpp_12834
crossref_primary_10_1111_1346_8138_17636
crossref_primary_10_7759_cureus_61679
crossref_primary_10_3390_diagnostics12123058
crossref_primary_10_1016_j_clindermatol_2020_06_006
crossref_primary_10_3390_medicina57101080
crossref_primary_10_1111_bjd_20939
crossref_primary_10_1111_wrr_13020
crossref_primary_10_1080_14737167_2020_1722104
crossref_primary_10_1016_j_cger_2023_09_002
crossref_primary_10_25208_vdv1185
crossref_primary_10_1111_jdv_16188
crossref_primary_10_4103_idoj_idoj_740_23
crossref_primary_10_1002_cia2_12175
crossref_primary_10_1111_bjd_18032
crossref_primary_10_1111_ddg_14310_g
crossref_primary_10_3389_fonc_2025_1505596
crossref_primary_10_1016_j_intimp_2021_108409
crossref_primary_10_26693_jmbs06_06_123
crossref_primary_10_1002_ccr3_8208
crossref_primary_10_3390_biomedicines9111555
crossref_primary_10_1111_ced_14041
crossref_primary_10_1080_14712598_2021_1874915
crossref_primary_10_1093_omcr_omaa001
crossref_primary_10_1111_bjd_16883
crossref_primary_10_1080_09546634_2020_1714540
crossref_primary_10_3238_arztebl_m2021_0136
crossref_primary_10_1002_jca_21829
crossref_primary_10_1155_2022_7583691
crossref_primary_10_1111_odi_15054
crossref_primary_10_1111_1346_8138_16265
crossref_primary_10_1186_s12903_023_03665_w
crossref_primary_10_4103_idoj_idoj_632_23
crossref_primary_10_1016_j_piel_2018_05_019
crossref_primary_10_1111_bjd_17591
crossref_primary_10_1111_ddg_14310
crossref_primary_10_1177_10781552221076755
crossref_primary_10_4274_turkderm_galenos_2022_81370
crossref_primary_10_2217_imt_2020_0189
crossref_primary_10_3390_dermatopathology10010012
crossref_primary_10_1016_j_ajog_2023_05_032
crossref_primary_10_1111_ajd_13560
crossref_primary_10_47102_annals_acadmed_sg_202020
crossref_primary_10_3389_fimmu_2019_01974
crossref_primary_10_1038_s41415_024_7074_8
crossref_primary_10_1097_ID9_0000000000000140
crossref_primary_10_3389_fmolb_2021_808536
crossref_primary_10_1056_NEJMoa2028564
crossref_primary_10_1111_1346_8138_16532
crossref_primary_10_1111_1346_8138_16653
crossref_primary_10_1016_j_jdermsci_2020_08_002
crossref_primary_10_17116_rosstomat2020130313
crossref_primary_10_1007_s12016_021_08882_1
crossref_primary_10_1111_bjd_18714
crossref_primary_10_1016_j_jid_2019_11_005
crossref_primary_10_1111_dth_15354
crossref_primary_10_1111_jdv_20149
crossref_primary_10_1159_000515229
crossref_primary_10_1007_s40257_020_00544_w
crossref_primary_10_1111_dth_13016
crossref_primary_10_1111_jop_12817
crossref_primary_10_1007_s00292_020_00795_8
crossref_primary_10_3389_fimmu_2019_01089
crossref_primary_10_1016_j_jfma_2022_12_005
crossref_primary_10_1136_bcr_2018_229026
crossref_primary_10_34019_1982_8047_2020_v46_31513
crossref_primary_10_7759_cureus_51830
crossref_primary_10_1111_ijd_17422
crossref_primary_10_1111_ijd_16331
crossref_primary_10_1111_jop_13239
crossref_primary_10_1111_dth_14079
crossref_primary_10_1111_dth_13027
crossref_primary_10_1007_s13671_022_00369_2
crossref_primary_10_1590_abd1806_4841_2019940206
crossref_primary_10_2340_actadv_v105_27140
crossref_primary_10_1111_scd_12454
crossref_primary_10_1080_21645515_2022_2151290
crossref_primary_10_1097_JD9_0000000000000088
crossref_primary_10_3389_fimmu_2023_1114586
crossref_primary_10_3390_vetsci9040153
crossref_primary_10_1016_j_jds_2024_10_002
crossref_primary_10_1002_ccr3_4494
crossref_primary_10_1038_s41467_024_51747_2
crossref_primary_10_1111_1346_8138_16597
crossref_primary_10_1542_pir_2021_005125
crossref_primary_10_1111_bjd_18814
crossref_primary_10_3892_etm_2019_7964
crossref_primary_10_1308_rcsfdj_2023_7
crossref_primary_10_2147_DDDT_S306046
crossref_primary_10_5937_mp72_33186
crossref_primary_10_7861_clinmed_2021_0232
crossref_primary_10_1038_s41598_022_11387_2
crossref_primary_10_1111_dth_12827
crossref_primary_10_1007_s11427_022_2212_5
crossref_primary_10_1007_s13555_018_0271_0
crossref_primary_10_1016_j_mpmed_2021_04_004
crossref_primary_10_1111_bjd_20782
crossref_primary_10_25259_IJDVL_469_20
crossref_primary_10_1007_s13671_019_00272_3
crossref_primary_10_1590_abd1806_4841_20199011
crossref_primary_10_1007_s40257_019_00497_9
crossref_primary_10_1111_ajd_13804
crossref_primary_10_3390_jcm11143968
crossref_primary_10_1080_1744666X_2020_1672535
crossref_primary_10_1111_ced_14916
crossref_primary_10_56951_medicinus_v34i3_79
crossref_primary_10_1111_bjd_18482
crossref_primary_10_33667_2078_5631_2020_12_24_26
crossref_primary_10_1007_s00105_019_4385_9
crossref_primary_10_1016_S0140_6736_19_31778_7
crossref_primary_10_15570_actaapa_2023_27
crossref_primary_10_1007_s10238_024_01354_8
crossref_primary_10_1016_j_jaad_2020_11_075
crossref_primary_10_25259_IJDVL_551_2022
crossref_primary_10_29262_ram_v68i1_826
crossref_primary_10_29176_2590843X_1628
crossref_primary_10_3389_fimmu_2019_01418
crossref_primary_10_1016_j_jds_2020_07_016
crossref_primary_10_1097_01_EWX_0000542472_35180_f9
crossref_primary_10_7759_cureus_8805
crossref_primary_10_1007_s10238_022_00823_2
crossref_primary_10_1016_j_jid_2021_11_022
crossref_primary_10_1111_dth_15032
crossref_primary_10_1124_pharmrev_120_000121
Cites_doi 10.1046/j.1365-2230.2000.00624.x
10.1016/0190-9622(90)70004-2
10.1111/j.1365-2133.1978.tb01630.x
10.1001/jamadermatol.2013.8175
10.1345/aph.1A047
10.1111/bjd.14408
10.1016/j.jaad.2007.05.024
10.1111/j.1365-4362.1990.tb04765.x
10.1001/archderm.1969.01610250123031
10.1038/jid.2008.172
10.1111/jdv.12080
10.1001/archderm.1963.01590130018006
10.2340/0001555575150152
10.1046/j.1468-3083.2002.00413.x
10.1016/j.det.2011.06.007
10.1046/j.1365-2230.2000.00622.x
10.7326/0003-4819-150-10-200905190-00004
10.1007/s001980200108
10.1001/jamadermatol.2014.1939
10.1111/j.1365-4362.1995.tb04430.x
10.1046/j.1365-2133.2002.04838.x
10.1159/000287254
10.1002/jca.21268
10.1001/archderm.136.12.1569
10.1111/j.1610-0378.2005.04747.x
10.5070/D36NS4V35J
10.1111/j.1365-4632.2006.02916.x
10.1001/archderm.139.6.739
10.1007/BF00498776
10.1201/b18491-17
10.5070/D35JR0R66P
10.1001/archderm.1996.03890360091015
10.1111/j.1468-3083.2006.01873.x
10.1046/j.1365-2133.2001.04132.x
10.1159/000247795
10.4103/0378-6323.25780
10.1046/j.1365-2133.2001.04524.x
10.1111/j.1365-2230.1995.tb01327.x
10.1111/j.1529-8019.2010.01329.x
10.1111/1523-1747.ep12337524
10.1001/jamadermatol.2014.3674
10.1111/j.1440-0960.2005.00191.x
10.1016/j.clindermatol.2011.03.017
10.1001/archderm.142.11.1447
10.1001/archderm.1988.01670110072018
10.1111/j.1365-2133.2009.09034.x
10.1001/archderm.1971.04000190016003
10.1067/S0190-9622(03)00859-4
10.1080/08916930600972008
10.1046/j.1365-4362.1999.00624.x
10.1007/s00403-013-1355-4
10.2165/00128071-200708020-00004
10.1001/archderm.136.7.868
10.1111/j.1365-2133.1978.tb01631.x
10.1097/00000372-199708000-00017
10.1016/S0190-9622(79)80050-X
10.1111/j.1468-3083.2010.03584.x
10.1016/j.jaad.2010.06.033
10.1046/j.1365-2133.2003.05513.x
10.1111/j.1365-2133.2011.10411.x
10.1016/j.jaad.2013.05.016
10.1111/j.1440-0960.1996.tb01013.x
10.7326/0003-4819-112-4-303
10.1111/jdv.12772
10.1034/j.1600-0714.2002.00085.x
10.1111/bjd.12474
10.1111/1523-1747.ep12665364
10.1001/archderm.141.6.699
10.1067/mjd.2000.109297
10.1111/j.1346-8138.1979.tb01927.x
10.4103/0378-6323.31902
10.1111/j.1468-3083.1995.tb00109.x
10.1111/1346-8138.12486
10.1034/j.1600-0536.2001.044004229.x
10.1111/bjd.12198
10.1001/archderm.1996.03890260105016
10.1111/j.1468-3083.2010.03753.x
10.1016/S0190-9622(08)81506-X
10.2165/11586680-000000000-00000
10.1001/archderm.1972.01620140005001
10.1111/j.1601-0825.2008.01445.x
10.1684/ejd.2011.1169
10.1136/adc.88.2.96
10.1016/S0190-9622(94)70060-5
10.1038/jid.2010.91
10.1111/j.1468-3083.1995.tb00306.x
10.1111/j.1525-1470.1998.tb01370.x
10.1111/j.1365-2133.2008.09026.x
10.1056/NEJMoa062930
10.1111/j.1468-3083.2011.04294.x
10.1097/OGX.0b013e3181bea089
10.1046/j.1365-2133.2003.05269.x
10.1111/j.1365-2230.2009.03450.x
10.1001/archderm.1984.01650370050009
10.2165/11533290-000000000-00000
10.1111/j.1365-2249.2005.02834.x
10.1001/archderm.1976.01630260013004
10.1016/j.autrev.2014.12.002
10.1001/archderm.1996.03890360021005
10.1016/S0140-6736(17)30070-3
10.1001/archderm.135.10.1275
10.1684/ejd.2011.1611
10.1046/j.1365-2133.1999.02752.x
10.1111/j.1365-2133.2011.10585.x
10.1001/archderm.1974.01630120012002
10.1111/j.1365-4632.2004.02501.x
10.1046/j.1365-2133.2000.03686.x
10.3109/08916934.2011.606452
10.1001/archderm.136.9.1133
10.1172/JCI117349
10.1016/j.jaad.2015.04.038
10.1111/j.1365-2230.2004.01499.x
10.1684/ejd.2011.1428
10.1001/archderm.1997.03890390021002
10.1016/S0190-9622(96)80066-1
10.1111/j.1365-2133.2009.09208.x
10.1001/archderm.144.5.682
10.1159/000251868
10.1001/archderm.1988.01670110062013
10.1001/archderm.144.1.25
10.1001/archderm.142.5.570
10.1016/S0190-9622(88)70132-2
10.2165/11310380-000000000-00000
10.1016/S0190-9622(08)80854-7
10.1111/j.1473-2130.2004.00098.x
10.1016/j.jaad.2014.05.071
10.1016/j.det.2011.07.001
10.2165/11311150-000000000-00000
10.1001/archderm.1979.04010040006002
10.1016/S0190-9622(00)90213-5
10.1111/j.1525-1470.2011.01514.x
10.1046/j.1365-2133.2000.03538.x
10.1111/jdv.12678
10.1111/j.1525-1470.2008.00808.x
10.1001/archderm.1973.01620180007002
10.1111/j.1468-3083.2008.02948.x
10.1001/archderm.1973.01620220028007
10.1016/j.jaad.2015.11.008
10.1309/3CAKPEU8JXGWLEDC
10.1001/archderm.134.9.1104
10.1001/archderm.1979.04010060036025
10.1111/j.1744-9987.2012.01075.x
10.1111/ced.12073
10.1016/j.jaad.2011.11.007
10.1016/S0190-9622(87)70226-6
10.1111/j.1468-3083.2010.03703.x
10.1503/cmaj.090449
10.1016/S0190-9622(03)02738-5
10.1016/j.jaad.2010.02.052
10.1111/j.1365-2133.1995.tb02497.x
10.1001/archderm.1972.01620130023006
10.1111/bjd.12972
10.1111/j.1365-2133.2011.10663.x
10.1001/archderm.1978.01640180023005
10.1093/rheumatology/ket409
10.1056/NEJMoa067752
10.1016/j.jaad.2008.01.012
10.1111/j.1468-3083.2007.02254.x
10.1016/j.jaad.2008.09.052
10.1111/j.1346-8138.2011.01354.x
10.1007/978-1-4899-7190-6_2
10.1371/journal.pone.0050696
10.1111/j.1468-3083.2007.02537.x
10.1111/j.1365-2230.1986.tb00423.x
10.1111/j.1365-2133.1975.tb02251.x
10.1016/S0190-9622(99)70203-3
10.1001/archderm.1969.01610250076018
10.1111/j.1346-8138.1978.tb01047.x
10.1016/S0190-9622(08)80651-2
10.1159/000249707
10.1159/000057886
10.1111/j.1365-2133.2005.06740.x
10.1016/j.clindermatol.2011.03.014
10.1111/j.1365-2133.1970.tb15707.x
10.1111/j.1468-3083.2011.04170.x
10.1038/jid.2008.192
10.1016/j.jaad.2008.09.014
10.1046/j.1365-2133.2003.05302.x
10.1159/000018090
10.1111/j.1525-1470.2007.00369.x
10.1016/S0190-9622(87)70069-3
10.1038/jid.2009.72
10.1016/S0190-9622(00)90014-8
10.1001/archderm.1989.01670180115020
10.1111/j.1365-4632.2008.03530.x
10.1001/archderm.1976.01630310024005
10.1111/j.1468-3083.2006.01587.x
10.1111/bjd.14410
10.1016/S0140-6736(99)00281-0
10.1111/j.1365-2133.2011.10732.x
10.1016/0190-9622(90)70352-I
10.1016/S0190-9622(98)70476-1
10.1111/j.1365-4632.2006.02766.x
10.1136/bmj.3.5714.84
10.1111/j.1346-8138.2003.tb00464.x
10.1016/j.det.2011.06.008
10.1046/j.1365-2133.2000.03660.x
10.1385/CRIAI:29:3:289
10.4103/0378-6323.55390
10.1001/archdermatol.2009.9
10.1111/j.1468-3083.2012.04717.x
10.1016/j.jaad.2010.04.039
10.1001/archderm.1988.01670110019004
10.1016/0030-4220(94)90322-0
10.1111/j.1468-3083.2007.02286.x
10.1111/j.1365-2133.1979.tb05571.x
10.1016/j.transci.2010.10.006
10.1159/000250907
10.1136/annrheumdis-2011-200477
10.1111/j.1365-2133.2009.09590.x
10.1111/j.1365-2133.1976.tb05168.x
10.1111/j.1365-2230.1995.tb01301.x
10.4103/0378-6323.53133
10.1001/archderm.135.1.54
10.1111/j.1468-3083.2010.03925.x
10.2340/00015555-2116
10.1111/j.1468-3083.2008.02715.x
10.1016/j.jaad.2012.08.010
10.1016/S0190-9622(99)70183-0
10.1111/j.1525-1470.2005.00118.x
10.1111/j.1365-4632.2006.02593.x
10.1001/jamadermatol.2013.6739
10.1111/j.1346-8138.1999.tb03463.x
10.1080/09546630701449080
10.1111/j.1468-3083.2006.02074.x
10.1093/rheumatology/kem146a
10.1046/j.1365-2133.1999.02612.x
10.1001/archderm.1977.01640090084013
10.1111/j.1365-4632.2010.04828.x
10.1001/archderm.1987.01660330116023
10.4103/0378-6323.41366
10.1001/archderm.1983.01650270033013
10.1111/j.1346-8138.2011.01382.x
10.1111/j.1365-4362.1995.tb04450.x
10.1080/08916930600972016
10.1111/j.1365-2133.2009.09246.x
10.1016/0190-9622(90)70277-O
10.1111/j.1365-2133.1989.tb04165.x
10.1016/j.jaad.2015.10.051
10.1111/j.1468-3083.2010.03610.x
10.1111/pde.12744
10.1111/j.1744-9987.2009.00688.x
10.1111/j.1365-4362.1990.tb04767.x
10.1016/S0190-9622(81)70033-1
10.1016/j.jaad.2010.06.003
10.1111/j.1600-0625.2010.01069.x
10.1001/archdermatol.2011.3320
10.1001/archderm.131.11.1339
10.1186/1471-5945-4-10
10.1111/j.1468-3083.2006.02044.x
10.1038/jid.1969.166
10.2334/josnusd.52.449
10.1002/art.1780401213
10.1111/jdv.12175
10.1002/jca.20300
10.1111/j.1365-2133.1982.tb00909.x
ContentType Journal Article
Copyright 2017 British Association of Dermatologists
Copyright © 2017 British Association of Dermatologists
Copyright_xml – notice: 2017 British Association of Dermatologists
– notice: Copyright © 2017 British Association of Dermatologists
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
NAPCQ
7X8
DOI 10.1111/bjd.15930
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2133
EndPage 1201
ExternalDocumentID 29192996
10_1111_bjd_15930
BJD15930
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Practice Guideline
GrantInformation_xml – fundername: British Association of Dermatologists
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
23N
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
5WD
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AABZA
AACZT
AAESR
AAEVG
AAHHS
AANHP
AAONW
AAPGJ
AAPXW
AARHZ
AASGY
AAUAY
AAVAP
AAWDT
AAXRX
AAZKR
ABCQN
ABCUV
ABDFA
ABEJV
ABEML
ABNHQ
ABOCM
ABPTD
ABPVW
ABQNK
ABWST
ABXGK
ABXVV
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACFRR
ACGFS
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUTJ
ACXBN
ACXQS
ACYXJ
ACZBC
ADBBV
ADEOM
ADIPN
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADQBN
ADVEK
ADVOB
ADXAS
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFFNX
AFGKR
AFPWT
AFYAG
AFZJQ
AGMDO
AGQXC
AGUTN
AHEFC
AHMMS
AIACR
AIURR
AIWBW
AJAOE
AJBDE
AJEEA
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
APJGH
ASPBG
ATGXG
ATUGU
AVNTJ
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BCRHZ
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
H13
HF~
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
KOP
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NU-
O66
O9-
OAUYM
OCZFY
OIG
OJZSN
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
ROX
RX1
SUPJJ
TEORI
TMA
UB1
V9Y
VVN
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
Y6R
YFH
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
ABGNP
ABJNI
ABPQP
ABVGC
ACVCV
ADMTO
ADNBA
AEFGJ
AEMQT
AFFQV
AFXAL
AGORE
AGQPQ
AGXDD
AHGBF
AIDQK
AIDYY
AJBYB
AJDVS
AJNCP
ALXQX
CITATION
OBFPC
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c4540-a1b686ae175e13a2064d20348afccbc16f58ffaf276e923ea04144c97ef1a6053
IEDL.DBID DR2
ISSN 0007-0963
1365-2133
IngestDate Fri Jul 11 00:53:33 EDT 2025
Fri Jul 25 19:49:51 EDT 2025
Mon Jul 21 05:39:15 EDT 2025
Thu Apr 24 23:06:21 EDT 2025
Thu Jul 03 08:39:25 EDT 2025
Wed Jan 22 16:21:09 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://doi.wiley.com/10.1002/tdm_license_1.1
http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4540-a1b686ae175e13a2064d20348afccbc16f58ffaf276e923ea04144c97ef1a6053
Notes Funding sources
Development of this guideline has been funded independently by the British Association of Dermatologists.
BAD
Scientific Administrator), L.S. Exton
Produced in 2003 by the British Association of Dermatologists; reviewed and updated 2017.
.
Clinical Standards Manager).
NICE has accredited the process used by the British Association of Dermatologists to produce guidelines. The renewed accreditation is valid until 31 May 2021 and applies to guidance produced using the process described in updated guidance for writing a British Association of Dermatologists clinical guidance – the adoption of the GRADE methodology 2016. The original accreditation term began on 12 May 2010. More information on accreditation can be viewed at
Clinical Standards Unit, which includes the Therapy & Guidelines (T&G) Subcommittee. Members of the Clinical Standards Unit who have been involved are P.M. McHenry (Chair T&G), K. Gibbon, D.A. Buckley, T.A. Leslie, E.C. Mallon, S. Wakelin, S. Ungureanu, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, J. Natkunarajah, F.S. Worsnop, N. Chiang, C.E. Duarte Williamson, J. Donnelly (British National Formulary), C. Saunders (British Dermatological Nursing Group), A.G. Brain
www.nice.org.uk/accreditation
K.E.H., D.B., R.W.G., P.J.H., J.F.S. and P.D.Y. are members of the guideline development group, with technical support provided by L.S.E. and M.F.M.M.
Conflicts of interest
Information Scientist) and M.F. Mohd Mustapa
This is an updated guideline prepared for the British Association of Dermatologists
None declared.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Instructional Material/Guideline-3
content type line 23
OpenAccessLink https://kclpure.kcl.ac.uk/ws/files/84233149/British_Association_of_Dermatologists_HARMAN_Publishedonline30November2017_GREEN_AAM.pdf
PMID 29192996
PQID 1970204648
PQPubID 36393
PageCount 32
ParticipantIDs proquest_miscellaneous_1971645359
proquest_journals_1970204648
pubmed_primary_29192996
crossref_primary_10_1111_bjd_15930
crossref_citationtrail_10_1111_bjd_15930
wiley_primary_10_1111_bjd_15930_BJD15930
PublicationCentury 2000
PublicationDate November 2017
2017-11-00
20171101
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle British journal of dermatology (1951)
PublicationTitleAlternate Br J Dermatol
PublicationYear 2017
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 2001; 144
2001; 145
2013; 69
1973; 107
2004; 29
1984; 168
2013; 68
1995; 34
2004; 4
1999; 40
2012; 16
2010; 182
2012; 15
1973; 108
2001; 44
2012; 11
2016; 33
1984; 50
1995; 20
1998; 15
1991; 182
1979; 6
1996; 132
2008; 22
1979; 1
2012; 26
2012; 22
2010; 9
2007; 17
2007; 18
2009; 64
1986; 11
2009; 60
1999; 26
1981; 4
2008; 58
1971; 104
2008; 128
2010; 162
2012; 39
2007; 10
1998; 134
2012; 30
2006; 355
2014; 306
2009; 75
1989; 125
1999; 38
1989; 120
2008; 47
2005; 1
2005; 3
1970; 83
1999; 354
1990; 112
2012; 45
1977; 113
2017; 389
2008; 130
2016; 22
1973; 147
1984; 120
2013; 28
2013; 27
1975; 58
2014; 170
2008; 74
1996; 37
1996; 34
1970; 3
2003; 99
2005; 141
2005; 142
2000
2003; 9
2003; 2
1999; 135
2007; 21
2007; 24
2003; 88
2014; 53
2002; 36
2005; 153
2002; 31
2015; 95
1969; 53
1999; 140
2006; 18
2002
2007; 57
2015; 151
2007; 357
2013; 38
1976; 94
2003; 69
1995; 104
2010; 130
2006; 142
2002; 204
2009; 8
2000; 142
2000; 143
2015
2009; 1
2014; 71
2007; 46
2002; 16
2010; 11
1997; 40
1963; 87
1993; 28
2000; 136
2010; 19
2015; 73
2002; 13
2006; 39
2010; 221
1995; 133
2007; 73
2014; 28
1975; 93
1995; 131
2010; 23
1976; 112
2009; 13
2006; 20
2010; 24
1990
2002; 147
2011; 64
2007; 8
2011; 63
1994; 77
2003; 49
2011; 65
2009; 129
1972; 106
1989; 62
2010; 35
1988; 18
1994; 89
2014; 150
1978; 156
2014; 41
1995; 4
2003; 30
1995; 5
2010; 43
1990; 22
1990; 23
2006; 45
1990; 29
1999; 198
2007; 80
1994; 94
1974; 110
2016; 175
2005; 11
2010; 52
1995; 75
2012; 166
2006; 72
1979; 100
1982; 106
2009; 160
2000; 43
2000; 42
2003; 13
1978; 5
2013; 169
2016; 74
2009; 150
2011; 12
2008; 144
2005; 29
2005; 22
1983; 119
1998; 47
2012; 71
1979; 115
1997; 109
1997; 19
2011; 21
2009; 161
2011; 26
2011; 25
2011; 28
2012; 67
2011; 29
1994; 30
2011; 165
2009; 23
2015; 14
1987; 123
2003; 139
2000; 25
1978; 98
2008; 18
1997; 133
2008; 14
1988; 124
1978; 114
2012; 148
2005; 44
1987; 17
2009; 26
2005; 46
1969; 100
1987; 16
1998; 38
2015; 29
2003; 149
2011; 50
1988; 7
2009; 145
1988; 68
2003; 148
2012; 7
1969; 235
e_1_2_32_153_1
e_1_2_32_199_1
e_1_2_32_80_1
e_1_2_32_115_1
e_1_2_32_191_1
e_1_2_32_65_1
e_1_2_32_88_1
Krakowski A (e_1_2_32_89_1) 1969; 100
e_1_2_32_138_1
e_1_2_32_42_1
e_1_2_32_285_1
e_1_2_32_262_1
e_1_2_32_16_1
e_1_2_32_39_1
e_1_2_32_201_1
Rosenberg FR (e_1_2_32_68_1) 1976; 112
e_1_2_32_224_1
e_1_2_32_188_1
e_1_2_32_209_1
e_1_2_32_91_1
e_1_2_32_99_1
e_1_2_32_9_1
Auerbach R (e_1_2_32_200_1) 1979; 115
e_1_2_32_180_1
e_1_2_32_104_1
e_1_2_32_76_1
e_1_2_32_127_1
e_1_2_32_30_1
Roenigk HH (e_1_2_32_94_1) 1973; 107
Lever WF (e_1_2_32_162_1) 1969; 100
e_1_2_32_273_1
e_1_2_32_27_1
Gürcan H (e_1_2_32_161_1) 2011; 63
e_1_2_32_258_1
e_1_2_32_235_1
e_1_2_32_154_1
e_1_2_32_177_1
e_1_2_32_116_1
e_1_2_32_139_1
e_1_2_32_192_1
Anderson I (e_1_2_32_252_1) 2003; 99
e_1_2_32_64_1
Mamelak AJ (e_1_2_32_272_1) 2007; 80
e_1_2_32_41_1
e_1_2_32_261_1
e_1_2_32_284_1
e_1_2_32_38_1
e_1_2_32_269_1
e_1_2_32_223_1
e_1_2_32_2_1
e_1_2_32_120_1
e_1_2_32_143_1
e_1_2_32_208_1
e_1_2_32_90_1
e_1_2_32_98_1
e_1_2_32_105_1
e_1_2_32_128_1
e_1_2_32_181_1
e_1_2_32_52_1
e_1_2_32_75_1
Penneys NS (e_1_2_32_189_1) 1976; 112
Gokhale NR (e_1_2_32_141_1) 2003; 69
e_1_2_32_26_1
e_1_2_32_49_1
e_1_2_32_234_1
Ormond M (e_1_2_32_36_1) 2016; 22
e_1_2_32_151_1
Søndergaard K (e_1_2_32_207_1) 1995; 75
e_1_2_32_159_1
e_1_2_32_40_1
e_1_2_32_86_1
e_1_2_32_174_1
e_1_2_32_113_1
e_1_2_32_197_1
e_1_2_32_264_1
e_1_2_32_14_1
e_1_2_32_37_1
e_1_2_32_226_1
e_1_2_32_249_1
e_1_2_32_3_1
Shahidi‐Dadras M (e_1_2_32_73_1) 2007; 10
e_1_2_32_203_1
e_1_2_32_287_1
e_1_2_32_163_1
e_1_2_32_97_1
e_1_2_32_13_1
e_1_2_32_148_1
e_1_2_32_74_1
e_1_2_32_125_1
e_1_2_32_186_1
Roujeau JC (e_1_2_32_213_1) 1988; 7
e_1_2_32_51_1
e_1_2_32_102_1
e_1_2_32_275_1
Martin LK (e_1_2_32_53_1) 2009; 1
Aoyama Y (e_1_2_32_158_1) 2011; 21
e_1_2_32_25_1
e_1_2_32_48_1
e_1_2_32_290_1
Werth VP (e_1_2_32_87_1) 1996; 132
e_1_2_32_237_1
Baum S (e_1_2_32_171_1) 2012; 22
e_1_2_32_152_1
Bystryn JC (e_1_2_32_211_1) 1988; 124
e_1_2_32_137_1
e_1_2_32_24_1
Blaszczyk M (e_1_2_32_212_1) 1989; 125
e_1_2_32_85_1
e_1_2_32_114_1
e_1_2_32_175_1
e_1_2_32_198_1
e_1_2_32_62_1
e_1_2_32_263_1
e_1_2_32_286_1
Penzer R (e_1_2_32_250_1) 2012; 11
e_1_2_32_190_1
e_1_2_32_59_1
e_1_2_32_202_1
e_1_2_32_225_1
e_1_2_32_248_1
e_1_2_32_4_1
e_1_2_32_96_1
e_1_2_32_12_1
e_1_2_32_35_1
e_1_2_32_126_1
e_1_2_32_149_1
e_1_2_32_50_1
e_1_2_32_103_1
e_1_2_32_251_1
e_1_2_32_274_1
Ryan JG (e_1_2_32_15_1) 1971; 104
e_1_2_32_47_1
e_1_2_32_236_1
e_1_2_32_259_1
Masood Q (e_1_2_32_140_1) 2003; 69
Mashkilleyson N (e_1_2_32_169_1) 1988; 68
Aoyama Y (e_1_2_32_215_1) 2008; 18
e_1_2_32_23_1
e_1_2_32_46_1
e_1_2_32_172_1
e_1_2_32_111_1
e_1_2_32_157_1
e_1_2_32_195_1
e_1_2_32_61_1
e_1_2_32_84_1
e_1_2_32_134_1
e_1_2_32_220_1
e_1_2_32_281_1
e_1_2_32_108_1
e_1_2_32_58_1
Krain LS (e_1_2_32_17_1) 1974; 110
e_1_2_32_5_1
e_1_2_32_228_1
e_1_2_32_243_1
e_1_2_32_289_1
e_1_2_32_266_1
e_1_2_32_95_1
e_1_2_32_11_1
e_1_2_32_57_1
e_1_2_32_34_1
e_1_2_32_184_1
e_1_2_32_100_1
e_1_2_32_146_1
Hodgson TA (e_1_2_32_240_1) 2003; 13
e_1_2_32_72_1
e_1_2_32_123_1
Krain LS (e_1_2_32_130_1) 1972; 106
e_1_2_32_231_1
e_1_2_32_69_1
e_1_2_32_216_1
e_1_2_32_277_1
e_1_2_32_60_1
e_1_2_32_150_1
Hughes E (e_1_2_32_247_1) 2000
e_1_2_32_22_1
e_1_2_32_45_1
e_1_2_32_112_1
e_1_2_32_135_1
e_1_2_32_173_1
e_1_2_32_196_1
e_1_2_32_83_1
e_1_2_32_19_1
e_1_2_32_242_1
Feng S (e_1_2_32_278_1) 2011; 21
e_1_2_32_109_1
e_1_2_32_280_1
e_1_2_32_227_1
e_1_2_32_6_1
Nazemi‐Tabrizi M‐J (e_1_2_32_239_1) 2012; 15
Lever WF (e_1_2_32_164_1) 1972; 106
e_1_2_32_204_1
e_1_2_32_265_1
e_1_2_32_288_1
e_1_2_32_71_1
e_1_2_32_10_1
e_1_2_32_33_1
e_1_2_32_56_1
e_1_2_32_79_1
Piamphongsant T (e_1_2_32_165_1) 1975; 58
e_1_2_32_101_1
e_1_2_32_124_1
e_1_2_32_147_1
e_1_2_32_185_1
e_1_2_32_230_1
e_1_2_32_253_1
Sacchidanand S (e_1_2_32_142_1) 2003; 9
e_1_2_32_238_1
Penneys NS (e_1_2_32_187_1) 1973; 108
Azaña JM (e_1_2_32_221_1) 1997; 133
e_1_2_32_276_1
Pacor ML (e_1_2_32_241_1) 1998; 47
e_1_2_32_132_1
e_1_2_32_178_1
e_1_2_32_219_1
McCuin JB (e_1_2_32_257_1) 2006; 18
Lever WF (e_1_2_32_166_1) 1977; 113
e_1_2_32_21_1
e_1_2_32_44_1
e_1_2_32_67_1
e_1_2_32_170_1
e_1_2_32_117_1
e_1_2_32_193_1
e_1_2_32_155_1
e_1_2_32_18_1
e_1_2_32_283_1
e_1_2_32_7_1
Rook AH (e_1_2_32_218_1) 1989; 62
Armenti VT (e_1_2_32_260_1) 2002
e_1_2_32_222_1
e_1_2_32_268_1
Ruocco V (e_1_2_32_214_1) 1988; 124
e_1_2_32_245_1
e_1_2_32_93_1
Pasricha JS (e_1_2_32_136_1) 1984; 50
e_1_2_32_70_1
e_1_2_32_121_1
e_1_2_32_167_1
Euler HH (e_1_2_32_205_1) 1987; 123
Lever WF (e_1_2_32_63_1) 1984; 120
e_1_2_32_78_1
e_1_2_32_129_1
e_1_2_32_182_1
Brown D (e_1_2_32_246_1) 2009; 8
e_1_2_32_55_1
e_1_2_32_106_1
e_1_2_32_144_1
e_1_2_32_29_1
Bhat R (e_1_2_32_82_1) 2005; 11
e_1_2_32_271_1
e_1_2_32_210_1
Barnard GF (e_1_2_32_176_1) 1994; 89
e_1_2_32_279_1
Fellner MJ (e_1_2_32_131_1) 1978; 114
e_1_2_32_256_1
e_1_2_32_81_1
e_1_2_32_110_1
e_1_2_32_179_1
e_1_2_32_43_1
e_1_2_32_118_1
e_1_2_32_194_1
Pfutze M (e_1_2_32_32_1) 2007; 17
e_1_2_32_66_1
White R (e_1_2_32_254_1) 2005; 1
e_1_2_32_133_1
e_1_2_32_156_1
e_1_2_32_20_1
e_1_2_32_282_1
e_1_2_32_8_1
e_1_2_32_206_1
e_1_2_32_244_1
e_1_2_32_267_1
e_1_2_32_92_1
e_1_2_32_168_1
e_1_2_32_229_1
e_1_2_32_160_1
e_1_2_32_54_1
e_1_2_32_77_1
e_1_2_32_107_1
e_1_2_32_183_1
e_1_2_32_31_1
e_1_2_32_122_1
e_1_2_32_145_1
Iraji F (e_1_2_32_233_1) 2010; 9
e_1_2_32_270_1
e_1_2_32_119_1
e_1_2_32_28_1
e_1_2_32_217_1
e_1_2_32_232_1
e_1_2_32_255_1
References_xml – volume: 142
  start-page: 1447
  year: 2006
  end-page: 54
  article-title: A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus
  publication-title: Arch Dermatol
– volume: 2
  start-page: 161
  year: 2003
  end-page: 5
  article-title: Pemphigus can be induced by topical phenol as well as by foods and drugs that contain phenols or thiols
  publication-title: J Cosmet Dermatol
– volume: 20
  start-page: 189
  year: 1995
  end-page: 201
  article-title: Management of the immunobullous disorders. I Pemphigoid
  publication-title: Clin Exp Dermatol
– volume: 24
  start-page: 947
  year: 2010
  end-page: 52
  article-title: Pemphigus, analysis of 155 patients
  publication-title: J Eur Acad Dermatol Venereol
– volume: 5
  start-page: 222
  year: 1995
  end-page: 8
  article-title: Intramuscular gold therapy for young patients with pemphigus vulgaris: a prospective, open, clinical study utilizing a dermatologist/rheumatologist team approach
  publication-title: J Eur Acad Dermatol Venereol
– volume: 28
  start-page: 122
  year: 1993
  end-page: 4
  article-title: Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis
  publication-title: J Am Acad Dermatol
– volume: 25
  start-page: 206
  year: 2011
  end-page: 10
  article-title: High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi‐centre, comparative study
  publication-title: J Eur Acad Dermatol Venereol
– volume: 60
  start-page: 261
  year: 2009
  end-page: 9
  article-title: Quality‐of‐life assessment in patients with pemphigus using a minimum set of evaluation tools
  publication-title: J Am Acad Dermatol
– volume: 16
  start-page: 311
  year: 2012
  end-page: 20
  article-title: Immunoadsorption in dermatology
  publication-title: Ther Apher Dial
– volume: 26
  start-page: 236
  year: 1999
  end-page: 9
  article-title: Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method
  publication-title: J Dermatol
– volume: 143
  start-page: 455
  year: 2000
  end-page: 6
  article-title: Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange
  publication-title: Br J Dermatol
– volume: 19
  start-page: 411
  year: 1997
  end-page: 14
  article-title: Histopathologic findings in drug‐induced pemphigus
  publication-title: Am J Dermatopathol
– volume: 19
  start-page: 458
  year: 2010
  end-page: 63
  article-title: Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients
  publication-title: Exp Dermatol
– volume: 29
  start-page: 599
  year: 2011
  end-page: 606
  article-title: Evidence‐based treatments in pemphigus vulgaris and pemphigus foliaceus
  publication-title: Dermatol Clin
– volume: 57
  start-page: 622
  year: 2007
  end-page: 8
  article-title: Randomized controlled open‐label trial of four treatment regimens for pemphigus vulgaris
  publication-title: J Am Acad Dermatol
– volume: 80
  start-page: 335
  year: 2007
  end-page: 40
  article-title: Rituximab therapy in severe juvenile pemphigus vulgaris
  publication-title: Cutis
– volume: 11
  start-page: 21
  year: 2010
  end-page: 33
  article-title: A current review of juvenile pemphigus vulgaris: analysis of data on clinical outcomes
  publication-title: Am J Clin Dermatol
– volume: 9
  start-page: 2
  year: 2003
  article-title: Dexamethasone‐cyclophosphamide pulse therapy for autoimmune‐vesiculobullous disorders at Victoria hospital, Bangalore
  publication-title: Dermatol Online J
– volume: 21
  start-page: 1319
  year: 2007
  end-page: 24
  article-title: Desmoglein 1 and 3 enzyme‐linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity
  publication-title: J Eur Acad Dermatol Venereol
– volume: 130
  start-page: 369
  year: 2008
  end-page: 74
  article-title: Immunostaining with antibodies to desmoglein provides the diagnosis of drug‐induced pemphigus and allows prediction of outcome
  publication-title: Am J Clin Pathol
– volume: 123
  start-page: 1205
  year: 1987
  end-page: 10
  article-title: Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 136
  start-page: 1569
  year: 2000
  end-page: 70
  article-title: Diagnostic patterns and delays in pemphigus vulgaris: experience with 99 patients
  publication-title: Arch Dermatol
– volume: 28
  start-page: 186
  year: 2013
  end-page: 91
  article-title: Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities
  publication-title: J Eur Acad Dermatol Venereol
– volume: 30
  start-page: 547
  year: 1994
  end-page: 50
  article-title: Pemphigus in remission: value of negative direct immunofluorescence in management
  publication-title: J Am Acad Dermatol
– volume: 1
  start-page: 2
  year: 1979
  end-page: 31
  article-title: Pemphigus and pemphigoid. A review of the advances made since 1964
  publication-title: J Am Acad Dermatol
– volume: 52
  start-page: 449
  year: 2010
  end-page: 54
  article-title: Pemphigus vulgaris: effects on periodontal health
  publication-title: J Oral Sci
– volume: 11
  start-page: 315
  year: 2010
  end-page: 26
  article-title: Intravenous immunoglobulin therapy in autoimmune mucocutaneous blistering diseases: a review of the evidence for its efficacy and safety
  publication-title: Am J Clin Dermatol
– volume: 142
  start-page: 1135
  year: 2000
  end-page: 9
  article-title: The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus
  publication-title: Br J Dermatol
– volume: 132
  start-page: 203
  year: 1996
  end-page: 12
  article-title: The adjuvant therapy of pemphigus. An update
  publication-title: Arch Dermatol
– volume: 11
  start-page: 123
  year: 2010
  end-page: 9
  article-title: Dexamethasone‐cyclophosphamide pulse therapy in pemphigus: a review of 72 cases
  publication-title: Am J Clin Dermatol
– volume: 108
  start-page: 56
  year: 1973
  end-page: 60
  article-title: Gold sodium thiomalate treatment of pemphigus
  publication-title: Arch Dermatol
– volume: 31
  start-page: 339
  year: 2002
  end-page: 44
  article-title: High‐dose intravenous ‘pulse’ methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study
  publication-title: J Oral Pathol Med
– volume: 69
  start-page: 583
  year: 2013
  end-page: 8
  article-title: Assessment of the rate of long‐term complete remission off therapy in patients with pemphigus treated with different regimens including medium‐ and high‐dose corticosteroids
  publication-title: J Am Acad Dermatol
– start-page: 138
  year: 2015
  end-page: 46
– volume: 88
  start-page: 96
  year: 2003
  article-title: Caustic burn caused by potassium permanganate
  publication-title: Arch Dis Child
– volume: 45
  start-page: 743
  year: 2006
  end-page: 6
  article-title: Healing effect of pilocarpine gel 4% on skin lesions of pemphigus vulgaris
  publication-title: Int J Dermatol
– volume: 124
  start-page: 1716
  year: 1988
  end-page: 18
  article-title: Plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris: a novelty or a reappraisal?
  publication-title: Arch Dermatol
– volume: 63
  start-page: 279
  year: 2011
  end-page: 91
  article-title: Management of pemphigus in pediatric patients
  publication-title: Minerva Pediatr
– volume: 45
  start-page: 111
  year: 2012
  end-page: 18
  article-title: Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update
  publication-title: Autoimmunity
– volume: 133
  start-page: 83
  year: 1995
  end-page: 7
  article-title: The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11‐year period
  publication-title: Br J Dermatol
– volume: 139
  start-page: 739
  year: 2003
  end-page: 42
  article-title: Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil
  publication-title: Arch Dermatol
– volume: 110
  start-page: 862
  year: 1974
  end-page: 5
  article-title: Pemphigus. Epidemiologic and survival characteristics of 59 patients, 1955–1973
  publication-title: Arch Dermatol
– volume: 129
  start-page: 289
  year: 2009
  end-page: 301
  article-title: B‐cell‐directed therapy for inflammatory skin diseases
  publication-title: J Invest Dermatol
– volume: 45
  start-page: 1308
  year: 2006
  end-page: 11
  article-title: Value of direct immunofluorescence in predicting remission in pemphigus vulgaris
  publication-title: Int J Dermatol
– volume: 112
  start-page: 303
  year: 1990
  end-page: 5
  article-title: Extracorporeal photochemotherapy for drug‐resistant pemphigus vulgaris
  publication-title: Ann Intern Med
– volume: 38
  start-page: 217
  year: 1999
  end-page: 21
  article-title: Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients
  publication-title: Int J Dermatol
– volume: 150
  start-page: 1331
  year: 2014
  end-page: 5
  article-title: Subcutaneous veltuzumab, a humanized anti‐CD20 antibody, in the treatment of refractory pemphigus vulgaris
  publication-title: JAMA Dermatol
– volume: 109
  start-page: 592
  year: 1997
  end-page: 6
  article-title: Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles
  publication-title: J Invest Dermatol
– volume: 58
  start-page: 1043
  year: 2008
  end-page: 6
  article-title: Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
  publication-title: J Am Acad Dermatol
– volume: 29
  start-page: 371
  year: 1990
  end-page: 4
  article-title: Dexamethasone‐cyclophosphamide pulse therapy in pemphigus
  publication-title: Int J Dermatol
– volume: 142
  start-page: 570
  year: 2006
  end-page: 6
  article-title: Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial
  publication-title: Arch Dermatol
– volume: 53
  start-page: 1377
  year: 2014
  end-page: 85
  article-title: Biologic therapies and pregnancy: the story so far
  publication-title: Rheumatology (Oxford)
– volume: 65
  start-page: 1064
  year: 2011
  end-page: 5
  article-title: Rituximab used as a first‐line single agent in the treatment of pemphigus vulgaris
  publication-title: J Am Acad Dermatol
– volume: 47
  start-page: 645
  year: 2008
  end-page: 7
  article-title: Pemphigus and chrysotherapy: all that glitters is not gold!
  publication-title: Int J Dermatol
– volume: 8
  start-page: 9
  year: 2009
  end-page: 12
  article-title: Demystifying the management of pemphigus
  publication-title: Dermatol Nurs
– volume: 71
  start-page: 669
  year: 2014
  end-page: 75
  article-title: Successful use of rituximab in the treatment of childhood and juvenile pemphigus
  publication-title: J Am Acad Dermatol
– volume: 4
  start-page: 325
  year: 1981
  end-page: 8
  article-title: Pemphigus vulgaris and plasma exchange: clinical and serologic studies
  publication-title: J Am Acad Dermatol
– volume: 119
  start-page: 215
  year: 1983
  end-page: 21
  article-title: Plasma exchange in pemphigus. Uncontrolled study of ten patients
  publication-title: Arch Dermatol
– volume: 73
  start-page: 121
  year: 2007
  end-page: 2
  article-title: Prolonged remission of pemphigus induced by dexamethasone‐cyclophosphamide pulse therapy
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 100
  start-page: 70
  year: 1969
  end-page: 8
  article-title: Treatment of pemphigus vulgaris with methotrexate
  publication-title: Arch Dermatol
– volume: 87
  start-page: 12
  year: 1963
  end-page: 26
  article-title: Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years
  publication-title: Arch Dermatol
– volume: 3
  start-page: 84
  year: 1970
  end-page: 6
  article-title: Azathioprine in pemphigus vulgaris
  publication-title: BMJ
– volume: 20
  start-page: 898
  year: 2006
  end-page: 9
  article-title: Efficacy of topical PGE2 in recalcitrant oral lesions of pemphigus vulgaris: a clinical trial
  publication-title: J Eur Acad Dermatol Venereol
– volume: 141
  start-page: 699
  year: 2005
  end-page: 702
  article-title: Dapsone as a glucocorticoid‐sparing agent in maintenance‐phase pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 136
  start-page: 868
  year: 2000
  end-page: 72
  article-title: Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus
  publication-title: Arch Dermatol
– volume: 53
  start-page: 390
  year: 1969
  end-page: 9
  article-title: The use of human skin for the detection of anti‐epithelial autoantibodies. A diagnostic and prognostic test
  publication-title: J Invest Dermatol
– volume: 140
  start-page: 84
  year: 1999
  end-page: 9
  article-title: Pemphigus vulgaris: the manifestations and long‐term management of 55 patients with oral lesions
  publication-title: Br J Dermatol
– volume: 18
  start-page: 20
  year: 2006
  end-page: 5
  article-title: Autoimmune bullous diseases: diagnosis and management
  publication-title: Dermatol Nurs
– volume: 22
  start-page: 35
  year: 1990
  end-page: 40
  article-title: Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies
  publication-title: J Am Acad Dermatol
– volume: 25
  start-page: 1073
  year: 2011
  end-page: 9
  article-title: Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 22
  start-page: 461
  year: 2005
  end-page: 4
  article-title: Successful treatment of refractory childhood pemphigus vulgaris with anti‐CD20 monoclonal antibody (rituximab)
  publication-title: Pediatr Dermatol
– volume: 389
  start-page: 2031
  year: 2017
  end-page: 40
  article-title: First‐line rituximab combined with short‐term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel‐group, open‐label randomised trial
  publication-title: Lancet
– volume: 22
  start-page: 1070
  year: 2008
  end-page: 5
  article-title: Anti‐desmoglein IgG autoantibodies in patients with pemphigus in remission
  publication-title: J Eur Acad Dermatol Venereol
– volume: 161
  start-page: 313
  year: 2009
  end-page: 19
  article-title: The use of sulfasalazine and pentoxifylline (low‐cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study
  publication-title: Br J Dermatol
– volume: 34
  start-page: 875
  year: 1995
  end-page: 82
  article-title: Dexamethasone‐cyclophosphamide pulse therapy for pemphigus
  publication-title: Int J Dermatol
– volume: 1
  start-page: CD006263
  year: 2009
  article-title: Interventions for pemphigus vulgaris and pemphigus foliaceus
  publication-title: Cochrane Database Syst Rev
– volume: 47
  start-page: 183
  year: 1998
  end-page: 6
  article-title: [Topical cyclosporine in the treatment of oral pemphigus]
  publication-title: Minerva Stomatol
– volume: 11
  start-page: S1
  issue: Suppl.
  year: 2012
  end-page: 19
  article-title: Best practice in emollient therapy – a statement for healthcare professionals
  publication-title: Dermatol Nurs
– volume: 100
  start-page: 117
  year: 1969
  article-title: Pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 23
  start-page: 129
  year: 2009
  end-page: 31
  article-title: A study on plucked hair as a substrate for direct immunofluorescence in pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 143
  start-page: 343
  year: 2000
  end-page: 8
  article-title: A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype
  publication-title: Br J Dermatol
– volume: 125
  start-page: 843
  year: 1989
  end-page: 4
  article-title: Indications for future studies on the treatment of pemphigus with plasmapheresis
  publication-title: Arch Dermatol
– volume: 128
  start-page: 2850
  year: 2008
  end-page: 8
  article-title: Rituximab exerts a dual effect in pemphigus vulgaris
  publication-title: J Invest Dermatol
– volume: 135
  start-page: 54
  year: 1999
  end-page: 6
  article-title: Mycophenolate is effective in the treatment of pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 357
  start-page: 545
  year: 2007
  end-page: 52
  article-title: A single cycle of rituximab for the treatment of severe pemphigus
  publication-title: N Engl J Med
– volume: 198
  start-page: 140
  year: 1999
  end-page: 4
  article-title: Short‐time extracorporeal photochemotherapy in the treatment of drug‐resistant autoimmune bullous diseases
  publication-title: Dermatology
– volume: 28
  start-page: 56
  year: 2013
  end-page: 63
  article-title: Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine
  publication-title: J Clin Apher
– volume: 124
  start-page: 1702
  year: 1988
  end-page: 4
  article-title: Plasmapheresis therapy of pemphigus
  publication-title: Arch Dermatol
– volume: 30
  start-page: 84
  year: 2012
  end-page: 94
  article-title: Current therapy of the pemphigus group
  publication-title: Clin Dermatol
– volume: 36
  start-page: 1108
  year: 2002
  end-page: 9
  article-title: Dexamethasone pharmacokinetics after high‐dose oral therapy for pemphigus
  publication-title: Ann Pharmacother
– volume: 132
  start-page: 1435
  year: 1996
  end-page: 9
  article-title: Treatment of pemphigus vulgaris with brief, high‐dose intravenous glucocorticoids
  publication-title: Arch Dermatol
– volume: 7
  start-page: 195
  year: 1988
  end-page: 200
  article-title: Plasmapheresis therapy of pemphigus and bullous pemphigoid
  publication-title: Semin Dermatol
– volume: 106
  start-page: 491
  year: 1972
  end-page: 7
  article-title: Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970
  publication-title: Arch Dermatol
– volume: 1
  start-page: 104
  year: 2005
  end-page: 9
  article-title: Evidence for atraumatic soft silicone wound dressing use
  publication-title: Wounds
– volume: 69
  start-page: 334
  year: 2003
  end-page: 7
  article-title: Treatment of pemphigus with intravenous pulse cyclophosphamide
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 68
  start-page: 404
  year: 2013
  end-page: 11
  article-title: Successful treatment of pemphigus with biweekly 1‐g infusions of rituximab: a retrospective study of 47 patients
  publication-title: J Am Acad Dermatol
– volume: 30
  start-page: 752
  year: 1994
  end-page: 7
  article-title: The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study
  publication-title: J Am Acad Dermatol
– volume: 39
  start-page: 601
  year: 2006
  end-page: 7
  article-title: IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris
  publication-title: Autoimmunity
– volume: 75
  start-page: 150
  year: 1995
  end-page: 2
  article-title: The steroid‐sparing effect of long‐term plasmapheresis in pemphigus
  publication-title: Acta Derm Venereol
– volume: 64
  start-page: 909
  year: 2011
  end-page: 10
  article-title: Pemphigus: directions for the future
  publication-title: J Am Acad Dermatol
– volume: 104
  start-page: 14
  year: 1971
  end-page: 20
  article-title: Pemphigus. A 20‐year survey of experience with 70 cases
  publication-title: Arch Dermatol
– volume: 22
  start-page: 580
  year: 2008
  end-page: 4
  article-title: Outcome of pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 46
  start-page: 1615
  year: 2007
  end-page: 16
  article-title: BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
  publication-title: Rheumatology (Oxford)
– volume: 13
  start-page: 142
  year: 2003
  end-page: 4
  article-title: Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris
  publication-title: Eur J Dermatol
– volume: 29
  start-page: 405
  year: 2015
  end-page: 14
  article-title: Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
  publication-title: J Eur Acad Dermatol Venereol
– volume: 39
  start-page: 660
  year: 2012
  end-page: 2
  article-title: Case of juvenile pemphigus vulgaris which responded to i.v. immunoglobulin therapy
  publication-title: J Dermatol
– volume: 71
  start-page: 955
  year: 2012
  end-page: 60
  article-title: Pulse versus daily oral cyclophosphamide for induction of remission in ANCA‐associated vasculitis: long‐term follow‐up
  publication-title: Ann Rheum Dis
– volume: 145
  start-page: 944
  year: 2001
  end-page: 8
  article-title: Pituitary‐adrenal function following dexamethasone‐cyclophosphamide pulse therapy for pemphigus
  publication-title: Br J Dermatol
– volume: 25
  start-page: 82
  year: 2011
  end-page: 6
  article-title: The role of therapeutic plasma exchange in pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 83
  start-page: 315
  year: 1970
  end-page: 23
  article-title: Immunosuppressants in the treatment of pemphigus
  publication-title: Br J Dermatol
– volume: 38
  start-page: 659
  year: 2013
  end-page: 64
  article-title: Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris
  publication-title: Clin Exp Dermatol
– volume: 14
  start-page: 323
  year: 2015
  end-page: 31
  article-title: A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab
  publication-title: Autoimmun Rev
– volume: 94
  start-page: 681
  year: 1976
  end-page: 6
  article-title: Pemphigus controlled by dapsone
  publication-title: Br J Dermatol
– volume: 21
  start-page: 58
  year: 2011
  end-page: 61
  article-title: Catabolism of pemphigus foliaceus autoantibodies by high‐dose IVIg therapy
  publication-title: Eur J Dermatol
– volume: 166
  start-page: 405
  year: 2012
  end-page: 12
  article-title: Low‐dose rituximab is effective in pemphigus
  publication-title: Br J Dermatol
– volume: 17
  start-page: 4
  year: 2007
  end-page: 11
  article-title: Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus
  publication-title: Eur J Dermatol
– volume: 130
  start-page: 2041
  year: 2010
  end-page: 8
  article-title: Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo‐controlled trial
  publication-title: J Invest Dermatol
– volume: 144
  start-page: 775
  year: 2001
  end-page: 80
  article-title: The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels
  publication-title: Br J Dermatol
– volume: 166
  start-page: 154
  year: 2012
  end-page: 60
  article-title: Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
  publication-title: Br J Dermatol
– volume: 115
  start-page: 728
  year: 1979
  end-page: 30
  article-title: Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 162
  start-page: 790
  year: 2010
  end-page: 7
  article-title: Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus
  publication-title: Br J Dermatol
– volume: 74
  start-page: 746
  year: 2016
  end-page: 53
  article-title: Future therapies for pemphigus vulgaris: rituximab and beyond
  publication-title: J Am Acad Dermatol
– volume: 23
  start-page: 701
  year: 1990
  end-page: 3
  article-title: Prolonged remission after cyclosporine therapy in pemphigus vulgaris: report of two young siblings
  publication-title: J Am Acad Dermatol
– volume: 27
  start-page: 1285
  year: 2013
  end-page: 92
  article-title: Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 6
  start-page: 359
  year: 1979
  end-page: 63
  article-title: Treatment of pemphigus with corticosteroids and cyclophosphamide
  publication-title: J Dermatol
– volume: 26
  start-page: 276
  year: 2011
  end-page: 85
  article-title: Extracorporeal photopheresis: how, when, and why
  publication-title: J Clin Apheresis
– volume: 150
  start-page: 266
  year: 2014
  end-page: 72
  article-title: Pemphigus disease activity measurements: Pemphigus Disease Area Index, Autoimmune Bullous Skin Disorder Intensity Score, and Pemphigus Vulgaris Activity Score
  publication-title: JAMA Dermatol
– volume: 28
  start-page: 998
  year: 1993
  end-page: 1000
  article-title: Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases
  publication-title: J Am Acad Dermatol
– volume: 24
  start-page: 172
  year: 2007
  end-page: 6
  article-title: Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment
  publication-title: Pediatr Dermatol
– volume: 22
  start-page: 21
  issue: Suppl. S2
  year: 2016
  article-title: An Oral Disease Severity Score (ODSS) validated for pemphigus vulgaris
  publication-title: Oral Dis
– volume: 120
  start-page: 44
  year: 1984
  end-page: 7
  article-title: Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982
  publication-title: Arch Dermatol
– volume: 39
  start-page: 141
  year: 2012
  end-page: 4
  article-title: Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires
  publication-title: J Dermatol
– volume: 29
  start-page: 663
  year: 2011
  end-page: 71
  article-title: Diagnosis and treatment of patients with autoimmune bullous disorders in Germany
  publication-title: Dermatol Clin
– volume: 166
  start-page: 844
  year: 2012
  end-page: 52
  article-title: Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult‐to‐treat pemphigus vulgaris
  publication-title: Br J Dermatol
– volume: 148
  start-page: 1222
  year: 2003
  end-page: 9
  article-title: Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus
  publication-title: Br J Dermatol
– volume: 35
  start-page: 245
  year: 2010
  end-page: 50
  article-title: Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus
  publication-title: Clin Exp Dermatol
– volume: 12
  start-page: 283
  year: 2011
  end-page: 4
  article-title: Pemphigus vulgaris with plaque‐type psoriasis successfully treated with cyclosporine monotherapy
  publication-title: Am J Clin Dermatol
– volume: 22
  start-page: 83
  year: 2012
  end-page: 7
  article-title: Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris
  publication-title: Eur J Dermatol
– volume: 4
  start-page: 10
  year: 2004
  article-title: Enhanced diagnostic immunofluorescence using biopsies transported in saline
  publication-title: BMC Dermatol
– volume: 144
  start-page: 682
  year: 2008
  end-page: 3
  article-title: Kinetics of response to conventional treatment in patients with pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 49
  start-page: 1059
  year: 2003
  end-page: 62
  article-title: Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris
  publication-title: J Am Acad Dermatol
– volume: 131
  start-page: 1339
  year: 1995
  end-page: 40
  article-title: Is the combination of tetracycline and nicotinamide therapy alone effective in pemphigus?
  publication-title: Arch Dermatol
– volume: 140
  start-page: 351
  year: 1999
  end-page: 7
  article-title: Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus
  publication-title: Br J Dermatol
– volume: 23
  start-page: 308
  year: 2010
  end-page: 11
  article-title: The efficacy of nicotinamide gel 4% as an adjuvant therapy in the treatment of cutaneous erosions of pemphigus vulgaris
  publication-title: Dermatol Ther
– volume: 74
  start-page: 1160
  year: 2016
  end-page: 5
  article-title: Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission
  publication-title: J Am Acad Dermatol
– start-page: 15
  year: 1990
  end-page: 34
– volume: 14
  start-page: 640
  year: 2008
  end-page: 3
  article-title: Periodontal status in patients with pemphigus vulgaris
  publication-title: Oral Dis
– volume: 49
  start-page: 276
  year: 2003
  end-page: 80
  article-title: Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus
  publication-title: J Am Acad Dermatol
– volume: 16
  start-page: 527
  year: 1987
  end-page: 33
  article-title: Azathioprine in the treatment of pemphigus vulgaris. A long‐term follow‐up
  publication-title: J Am Acad Dermatol
– volume: 95
  start-page: 928
  year: 2015
  end-page: 32
  article-title: Efficacy of rituximab for pemphigus: a systematic review and meta‐analysis of different regimens
  publication-title: Acta Derm Venereol
– volume: 21
  start-page: 1386
  year: 2007
  end-page: 91
  article-title: An alternate‐day corticosteroid regimen for pemphigus vulgaris. A 13‐year prospective study
  publication-title: J Eur Acad Dermatol Venereol
– volume: 60
  start-page: 595
  year: 2009
  end-page: 603
  article-title: A randomized double‐blind trial of intravenous immunoglobulin for pemphigus
  publication-title: J Am Acad Dermatol
– volume: 107
  start-page: 353
  year: 1973
  end-page: 7
  article-title: Pemphigus treatment with azathioprine. Clinical and immunologic correlation
  publication-title: Arch Dermatol
– volume: 64
  start-page: 490
  year: 2011
  end-page: 4
  article-title: Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission
  publication-title: J Am Acad Dermatol
– volume: 25
  start-page: 224
  year: 2000
  end-page: 6
  article-title: An unusual case of pemphigus vulgaris presenting as bilateral foot ulcers
  publication-title: Clin Exp Dermatol
– volume: 9
  start-page: 684
  year: 2010
  end-page: 6
  article-title: Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double‐blind, placebo‐controlled clinical trial
  publication-title: J Drugs Dermatol
– volume: 74
  start-page: 217
  year: 2008
  end-page: 21
  article-title: Current regimen of pulse therapy for pemphigus: minor modifications, improved results
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 21
  start-page: 79
  year: 2007
  end-page: 84
  article-title: Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double‐blind, randomized, controlled trial
  publication-title: J Eur Acad Dermatol Venereol
– volume: 26
  start-page: 855
  year: 2012
  end-page: 60
  article-title: Evaluation of mycophenolate mofetil as a steroid‐sparing agent in pemphigus: a randomized, prospective study
  publication-title: J Eur Acad Dermatol Venereol
– volume: 175
  start-page: 185
  year: 2016
  end-page: 6
  article-title: Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard
  publication-title: Br J Dermatol
– volume: 50
  start-page: 199
  year: 1984
  end-page: 203
  article-title: Pulse therapy with dexamethasone‐cyclophosphamide in pemphigus
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 34
  start-page: 645
  year: 1996
  end-page: 52
  article-title: Influence of treatment on the clinical course of pemphigus vulgaris
  publication-title: J Am Acad Dermatol
– volume: 113
  start-page: 1236
  year: 1977
  end-page: 41
  article-title: Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975
  publication-title: Arch Dermatol
– volume: 8
  start-page: 85
  year: 2007
  end-page: 92
  article-title: Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris
  publication-title: Am J Clin Dermatol
– volume: 23
  start-page: 1259
  year: 1990
  end-page: 63
  article-title: Topical cyclosporine for oral mucosal disorders
  publication-title: J Am Acad Dermatol
– volume: 15
  start-page: 381
  year: 1998
  end-page: 3
  article-title: Childhood pemphigus vulgaris treated with dapsone: a case report
  publication-title: Pediatr Dermatol
– volume: 112
  start-page: 962
  year: 1976
  end-page: 70
  article-title: Pemphigus: a 20‐year review of 107 patients treated with corticosteroids
  publication-title: Arch Dermatol
– volume: 106
  start-page: 657
  year: 1972
  end-page: 61
  article-title: Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid
  publication-title: Arch Dermatol
– volume: 42
  start-page: 85
  year: 2000
  end-page: 8
  article-title: The use of chlorambucil with prednisone in the treatment of pemphigus
  publication-title: J Am Acad Dermatol
– volume: 98
  start-page: 237
  year: 1978
  end-page: 41
  article-title: Pathogenicity of the intercellular antibodies of pemphigus and their periodic removal from the circulation by plasmapheresis
  publication-title: Br J Dermatol
– volume: 39
  start-page: 591
  year: 2006
  end-page: 9
  article-title: Pemphigus: a treatment update
  publication-title: Autoimmunity
– volume: 148
  start-page: 734
  year: 2012
  end-page: 9
  article-title: Effect of a single‐cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients
  publication-title: Arch Dermatol
– volume: 106
  start-page: 103
  year: 1982
  end-page: 4
  article-title: Plasma exchange in corticosteroid‐resistant pemphigus
  publication-title: Br J Dermatol
– volume: 204
  start-page: 228
  year: 2002
  end-page: 31
  article-title: Long‐term efficacy of dexamethasone‐cyclophosphamide pulse therapy in pemphigus
  publication-title: Dermatology
– volume: 68
  start-page: 413
  year: 1988
  end-page: 21
  article-title: Mucous membrane manifestations of pemphigus vulgaris. A 25‐year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin
  publication-title: Acta Derm Venereol
– volume: 30
  start-page: 108
  year: 2012
  end-page: 13
  article-title: Severity score indexes for blistering diseases
  publication-title: Clin Dermatol
– volume: 147
  start-page: 261
  year: 2002
  end-page: 5
  article-title: Monitoring disease activity in pemphigus with enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3
  publication-title: Br J Dermatol
– volume: 93
  start-page: 573
  year: 1975
  end-page: 6
  article-title: Treatment of pemphigus with cyclophosphamide
  publication-title: Br J Dermatol
– volume: 73
  start-page: 264
  year: 2015
  end-page: 71
  article-title: The role of adjuvant therapy in pemphigus: a systematic review and meta‐analysis
  publication-title: J Am Acad Dermatol
– volume: 42
  start-page: 422
  year: 2000
  end-page: 7
  article-title: Patterns of remission in pemphigus vulgaris
  publication-title: J Am Acad Dermatol
– volume: 7
  start-page: e50696
  year: 2012
  article-title: Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation
  publication-title: PLOS ONE
– volume: 98
  start-page: 243
  year: 1978
  article-title: Plasma exchange in the treatment of pemphigus vulgaris
  publication-title: Br J Dermatol
– volume: 161
  start-page: 723
  year: 2009
  end-page: 31
  article-title: Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid
  publication-title: Br J Dermatol
– volume: 50
  start-page: 1014
  year: 2011
  end-page: 19
  article-title: The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long‐term disease severity
  publication-title: Int J Dermatol
– volume: 165
  start-page: 646
  year: 2011
  end-page: 51
  article-title: Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients
  publication-title: Br J Dermatol
– volume: 13
  start-page: 229
  year: 2009
  end-page: 31
  article-title: Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis
  publication-title: Ther Apher Dial
– volume: 33
  start-page: e61
  year: 2016
  end-page: 4
  article-title: Rituximab therapy for childhood pemphigus vulgaris
  publication-title: Pediatr Dermatol
– volume: 67
  start-page: 617
  year: 2012
  end-page: 22
  article-title: Therapy with rituximab for autoimmune pemphigus: results from a single‐center observational study on 42 cases with long‐term follow‐up
  publication-title: J Am Acad Dermatol
– volume: 100
  start-page: 231
  year: 1979
  end-page: 2
  article-title: Plasma exchange in the treatment of pemphigus vulgaris
  publication-title: Br J Dermatol
– volume: 44
  start-page: 470
  year: 2005
  end-page: 6
  article-title: Pemphigus: analysis of 1209 cases
  publication-title: Int J Dermatol
– volume: 169
  start-page: 6
  year: 2013
  end-page: 10
  article-title: In a patient with an immunobullous disorder, is transportation of the skin biopsy in normal saline adequate for direct immunofluorescence analysis? A critically appraised topic
  publication-title: Br J Dermatol
– volume: 129
  start-page: 2404
  year: 2009
  end-page: 10
  article-title: Reliability and convergent validity of two outcome instruments for pemphigus
  publication-title: J Invest Dermatol
– volume: 136
  start-page: 1133
  year: 2000
  end-page: 8
  article-title: Minocycline‐induced hyperpigmentation in patients with pemphigus and pemphigoid
  publication-title: Arch Dermatol
– volume: 64
  start-page: 739
  year: 2009
  end-page: 49
  article-title: Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes
  publication-title: Obstet Gynecol Surv
– volume: 43
  start-page: 1058
  year: 2000
  end-page: 64
  article-title: The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris
  publication-title: J Am Acad Dermatol
– volume: 38
  start-page: 860
  year: 1998
  end-page: 1
  article-title: Use of topical cyclosporin in oral pemphigus
  publication-title: J Am Acad Dermatol
– volume: 46
  start-page: 239
  year: 2005
  end-page: 41
  article-title: Comparison of desmoglein ELISA and indirect immunofluorescence using two substrates (monkey oesophagus and normal human skin) in the diagnosis of pemphigus
  publication-title: Australas J Dermatol
– volume: 21
  start-page: 696
  year: 2011
  end-page: 9
  article-title: Analysis of 6 cases of drug‐induced pemphigus
  publication-title: Eur J Dermatol
– volume: 21
  start-page: 902
  year: 2007
  end-page: 7
  article-title: Gold: an old drug still working in refractory pemphigus
  publication-title: J Eur Acad Dermatol Venereol
– volume: 75
  start-page: 476
  year: 2009
  end-page: 82
  article-title: Randomized open comparative trial of dexamethasone‐cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 221
  start-page: 13
  year: 2010
  end-page: 16
  article-title: Rituximab in childhood pemphigus vulgaris: a long‐term follow‐up case and review of the literature
  publication-title: Dermatology
– volume: 99
  start-page: 61
  year: 2003
  article-title: Should potassium permanganate be used in wound care?
  publication-title: Nurs Times
– volume: 29
  start-page: 363
  year: 1990
  end-page: 7
  article-title: Pemphigus therapy with oral prednisolone regimens. A 5‐year study
  publication-title: Int J Dermatol
– volume: 28
  start-page: 771
  year: 2014
  end-page: 80
  article-title: Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication
  publication-title: J Eur Acad Dermatol Venereol
– volume: 169
  start-page: 916
  year: 2013
  end-page: 21
  article-title: Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients
  publication-title: Br J Dermatol
– volume: 11
  start-page: 49
  year: 1986
  end-page: 53
  article-title: The distribution of immunoglobulins and the C3 component of complement in multiple biopsies from the uninvolved and perilesional skin in pemphigus
  publication-title: Clin Exp Dermatol
– volume: 306
  start-page: 67
  year: 2014
  end-page: 74
  article-title: A prospective study on clinical response and cell‐mediated immunity of pemphigus patients treated with rituximab
  publication-title: Arch Dermatol Res
– volume: 30
  start-page: 713
  year: 2003
  end-page: 18
  article-title: Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy
  publication-title: J Dermatol
– volume: 160
  start-page: 725
  year: 2009
  end-page: 8
  article-title: Writing a British Association of Dermatologists clinical guideline: an update on the process and guidance for authors
  publication-title: Br J Dermatol
– volume: 124
  start-page: 1659
  year: 1988
  end-page: 63
  article-title: Controlled study of plasma exchange in pemphigus
  publication-title: Arch Dermatol
– volume: 133
  start-page: 287
  year: 1997
  end-page: 9
  article-title: Severe pemphigus foliaceus treated with extracorporeal photochemotherapy
  publication-title: Arch Dermatol
– volume: 182
  start-page: E839
  year: 2010
  end-page: 42
  article-title: AGREE II: advancing guideline development, reporting and evaluation in health care
  publication-title: CMAJ
– volume: 135
  start-page: 1275
  year: 1999
  end-page: 6
  article-title: Methotrexate as an adjuvant treatment for pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 25
  start-page: 236
  year: 2000
  end-page: 40
  article-title: Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3
  publication-title: Clin Exp Dermatol
– volume: 18
  start-page: 275
  year: 2007
  end-page: 8
  article-title: The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris
  publication-title: J Dermatolog Treat
– volume: 29
  start-page: 271
  year: 2004
  end-page: 2
  article-title: Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris
  publication-title: Clin Exp Dermatol
– volume: 4
  start-page: 131
  year: 1995
  end-page: 6
  article-title: Early treatment of pemphigus does not improve the prognosis. A review of 53 patients
  publication-title: J Eur Acad Dermatol Venereol
– volume: 29
  start-page: 777
  year: 2015
  end-page: 82
  article-title: An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
  publication-title: J Eur Acad Dermatol Venereol
– volume: 58
  start-page: 171
  year: 1975
  end-page: 6
  article-title: Pemphigus: combined treatment with methotrexate and prednisone
  publication-title: J Med Assoc Thai
– volume: 10
  start-page: 1
  year: 2007
  end-page: 6
  article-title: Pulse versus oral methylprednisolone therapy in pemphigus vulgaris
  publication-title: Arch Iran Med
– volume: 114
  start-page: 889
  year: 1978
  end-page: 94
  article-title: Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 40
  start-page: 167
  year: 1999
  end-page: 70
  article-title: The clinical phenotype of pemphigus is defined by the anti‐desmoglein autoantibody profile
  publication-title: J Am Acad Dermatol
– volume: 150
  start-page: 670
  year: 2009
  end-page: 80
  article-title: Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody‐associated vasculitis: a randomized trial
  publication-title: Ann Intern Med
– volume: 26
  start-page: 1377
  year: 2012
  end-page: 83
  article-title: Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 11
  start-page: 4
  year: 2005
  article-title: Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study
  publication-title: Dermatol Online J
– volume: 40
  start-page: 2187
  year: 1997
  end-page: 98
  article-title: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis
  publication-title: Arthritis Rheum
– volume: 34
  start-page: 438
  year: 1995
  end-page: 42
  article-title: Steroid‐pulse therapy in pemphigus vulgaris long term follow‐up
  publication-title: Int J Dermatol
– volume: 26
  start-page: 197
  year: 2009
  end-page: 202
  article-title: Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulin therapy
  publication-title: Pediatr Dermatol
– volume: 77
  start-page: 620
  year: 1994
  end-page: 2
  article-title: Pemphigus vulgaris in adolescence. A case presentation and review of the literature
  publication-title: Oral Surg Oral Med Oral Pathol
– volume: 151
  start-page: 878
  year: 2015
  end-page: 82
  article-title: Intralesional rituximab in the treatment of refractory oral pemphigus vulgaris
  publication-title: JAMA Dermatol
– volume: 147
  start-page: 179
  year: 1973
  end-page: 85
  article-title: Treatment of pemphigus and pemphigoid with azathioprine
  publication-title: Dermatologica
– volume: 69
  start-page: 97
  year: 2003
  end-page: 9
  article-title: Dexamethasone cyclophosphamide pulse therapy in pemphigus: experience in Kashmir valley
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 20
  start-page: 283
  year: 1995
  end-page: 93
  article-title: Management of the immunobullous disorders. II Pemphigus
  publication-title: Clin Exp Dermatol
– volume: 160
  start-page: 1098
  year: 2009
  end-page: 102
  article-title: An ‘ ‐of‐1’ placebo‐controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris
  publication-title: Br J Dermatol
– volume: 354
  start-page: 1491
  year: 1999
  end-page: 2
  article-title: Understanding barrier function of the skin
  publication-title: Lancet
– volume: 28
  start-page: 485
  year: 2011
  end-page: 93
  article-title: Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris
  publication-title: Pediatr Dermatol
– volume: 40
  start-page: 265
  year: 1999
  end-page: 8
  article-title: Mycophenolate mofetil in autoimmune and inflammatory skin disorders
  publication-title: J Am Acad Dermatol
– volume: 144
  start-page: 25
  year: 2008
  end-page: 32
  article-title: Multicenter randomized, double‐blind, placebo‐controlled, clinical trial of dapsone as a glucocorticoid‐sparing agent in maintenance‐phase pemphigus vulgaris
  publication-title: Arch Dermatol
– volume: 104
  start-page: 323
  year: 1995
  end-page: 8
  article-title: Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein‐1
  publication-title: J Invest Dermatol
– volume: 149
  start-page: 138
  year: 2003
  end-page: 45
  article-title: An evaluation of the usefulness of mycophenolate mofetil in pemphigus
  publication-title: Br J Dermatol
– volume: 355
  start-page: 1772
  year: 2006
  end-page: 9
  article-title: Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
  publication-title: N Engl J Med
– volume: 13
  start-page: 777
  year: 2002
  end-page: 87
  article-title: The epidemiology of corticosteroid‐induced osteoporosis: a meta‐analysis
  publication-title: Osteoporos Int
– volume: 75
  start-page: 373
  year: 2009
  end-page: 8
  article-title: Outcome of dexamethasone‐cyclophosphamide pulse therapy in pemphigus: a case series
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 168
  start-page: 219
  year: 1984
  end-page: 23
  article-title: Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus
  publication-title: Dermatologica
– volume: 182
  start-page: 207
  year: 1991
  end-page: 10
  article-title: Drug‐induced versus drug‐triggered pemphigus
  publication-title: Dermatologica
– volume: 89
  start-page: 2057
  year: 1994
  end-page: 9
  article-title: Sulfone syndrome in a patient receiving steroids for pemphigus
  publication-title: Am J Gastroenterol
– volume: 62
  start-page: 647
  year: 1989
  end-page: 52
  article-title: Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris – preliminary report
  publication-title: Yale J Biol Med
– volume: 142
  start-page: 1
  year: 2005
  end-page: 11
  article-title: Clinical uses of intravenous immunoglobulin
  publication-title: Clin Exp Immunol
– volume: 21
  start-page: 843
  year: 2007
  end-page: 4
  article-title: Complete remission of drug‐resistant pemphigus vegetans treated by extracorporeal photopheresis
  publication-title: J Eur Acad Dermatol Venereol
– volume: 115
  start-page: 428
  year: 1979
  end-page: 32
  article-title: Correlation of antibodies in skin and serum with disease severity in pemphigus
  publication-title: Arch Dermatol
– volume: 18
  start-page: 1262
  year: 1988
  end-page: 6
  article-title: Treatment of nine cases of pemphigus vulgaris with cyclosporine
  publication-title: J Am Acad Dermatol
– volume: 120
  start-page: 391
  year: 1989
  end-page: 5
  article-title: The usefulness of immunofluorescent tests in pemphigus patients in clinical remission
  publication-title: Br J Dermatol
– volume: 44
  start-page: 229
  year: 2001
  end-page: 34
  article-title: Effect of different moisturizers on SLS‐irritated human skin
  publication-title: Contact Dermatitis
– volume: 5
  start-page: 43
  year: 1978
  end-page: 7
  article-title: Pemphigus: a survey of 85 patients between 1970 and 1974
  publication-title: J Dermatol
– volume: 43
  start-page: 353
  year: 2010
  end-page: 9
  article-title: Remission of severe autoimmune bullous disorders induced by long‐term extracorporeal photochemotherapy
  publication-title: Transfus Apher Sci
– volume: 175
  start-page: 113
  year: 2016
  end-page: 21
  article-title: Serum and salivary IgG and IgA antibodies to Dsg3 in mucosal pemphigus vulgaris
  publication-title: Br J Dermatol
– year: 2000
– volume: 235
  start-page: 63
  year: 1969
  end-page: 77
  article-title: [Immunosuppressive therapy of pemphigus vulgaris. Preliminary results of azathioprine (Imuran) treatment)]
  publication-title: Arch Klin Exp Dermatol
– volume: 145
  start-page: 529
  year: 2009
  end-page: 35
  article-title: ELISA testing of anti‐desmoglein 1 and 3 antibodies in the management of pemphigus
  publication-title: Arch Dermatol
– volume: 24
  start-page: 1157
  year: 2010
  end-page: 65
  article-title: Adjuvant triamcinolone acetonide injections in oro‐pharyngeal pemphigus vulgaris
  publication-title: J Eur Acad Dermatol Venereol
– volume: 16
  start-page: 607
  year: 2002
  end-page: 11
  article-title: Dexamethasone pulse therapy in pemphigus
  publication-title: J Eur Acad Dermatol Venereol
– volume: 37
  start-page: 93
  year: 1996
  end-page: 5
  article-title: Minocycline is a useful adjuvant therapy for pemphigus
  publication-title: Australas J Dermatol
– volume: 134
  start-page: 1104
  year: 1998
  end-page: 7
  article-title: Treatment of pemphigus with gold
  publication-title: Arch Dermatol
– volume: 153
  start-page: 449
  year: 2005
  end-page: 51
  article-title: Long‐standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab
  publication-title: Br J Dermatol
– start-page: 121
  year: 2002
  end-page: 30
  article-title: Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation
  publication-title: Clinical Transplants
– volume: 3
  start-page: 200
  year: 2005
  end-page: 6
  article-title: Intravenous dexamethasone‐cyclophosphamide pulse therapy in comparison with oral methylprednisolone‐azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study
  publication-title: J Dtsch Dermatol Ges
– volume: 132
  start-page: 1499
  year: 1996
  end-page: 502
  article-title: Pulse glucocorticoid therapy. The ‘big shot’ revisited
  publication-title: Arch Dermatol
– volume: 170
  start-page: 1341
  year: 2014
  end-page: 9
  article-title: Clinical and immunological outcomes of high‐ and low‐dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer‐blinded study
  publication-title: Br J Dermatol
– volume: 41
  start-page: 471
  year: 2014
  end-page: 86
  article-title: Japanese guidelines for the management of pemphigus
  publication-title: J Dermatol
– volume: 15
  start-page: 42
  year: 2012
  end-page: 6
  article-title: Randomized trial of tacrolimus 0·1% ointment versus triamcinolone acetonide 0·1% paste in the treatment of oral pemphigus vulgaris
  publication-title: Iran J Dermatol
– volume: 18
  start-page: 557
  year: 2008
  end-page: 60
  article-title: Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high‐dose immunoglobulin to prevent rebound increase in pathogenic IgG
  publication-title: Eur J Dermatol
– volume: 45
  start-page: 518
  year: 2006
  end-page: 22
  article-title: Evaluation of desmoglein enzyme‐linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris
  publication-title: Int J Dermatol
– volume: 29
  start-page: 289
  year: 2005
  end-page: 94
  article-title: Intravenous immunoglobulin for treatment of pemphigus
  publication-title: Clin Rev Allergy Immunol
– volume: 112
  start-page: 185
  year: 1976
  end-page: 7
  article-title: Management of pemphigus with gold compounds: a long‐term follow‐up report
  publication-title: Arch Dermatol
– volume: 156
  start-page: 120
  year: 1978
  end-page: 3
  article-title: Dapsone in the treatment of pemphigus vulgaris
  publication-title: Dermatologica
– volume: 149
  start-page: 598
  year: 2003
  end-page: 605
  article-title: Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan‐linked polyvinylalcohol adsorber
  publication-title: Br J Dermatol
– volume: 94
  start-page: 59
  year: 1994
  end-page: 67
  article-title: Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus
  publication-title: J Clin Invest
– volume: 29
  start-page: 585
  year: 2011
  end-page: 90
  article-title: Management of autoimmune blistering diseases in pregnancy
  publication-title: Dermatol Clin
– volume: 72
  start-page: 203
  year: 2006
  end-page: 6
  article-title: Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus
  publication-title: Indian J Dermatol Venereol Leprol
– volume: 150
  start-page: 703
  year: 2014
  end-page: 8
  article-title: Durable remission of pemphigus with a fixed‐dose rituximab protocol
  publication-title: JAMA Dermatol
– volume: 64
  start-page: 903
  year: 2011
  end-page: 8
  article-title: A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus
  publication-title: J Am Acad Dermatol
– volume: 17
  start-page: 437
  year: 1987
  end-page: 42
  article-title: Use of cyclophosphamide in azathioprine failures in pemphigus
  publication-title: J Am Acad Dermatol
– ident: e_1_2_32_24_1
  doi: 10.1046/j.1365-2230.2000.00624.x
– ident: e_1_2_32_206_1
  doi: 10.1016/0190-9622(90)70004-2
– ident: e_1_2_32_197_1
  doi: 10.1111/j.1365-2133.1978.tb01630.x
– ident: e_1_2_32_35_1
  doi: 10.1001/jamadermatol.2013.8175
– ident: e_1_2_32_86_1
  doi: 10.1345/aph.1A047
– ident: e_1_2_32_26_1
  doi: 10.1111/bjd.14408
– ident: e_1_2_32_54_1
  doi: 10.1016/j.jaad.2007.05.024
– ident: e_1_2_32_64_1
  doi: 10.1111/j.1365-4362.1990.tb04765.x
– volume: 100
  start-page: 117
  year: 1969
  ident: e_1_2_32_89_1
  article-title: Pemphigus vulgaris
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1969.01610250123031
– ident: e_1_2_32_103_1
  doi: 10.1038/jid.2008.172
– ident: e_1_2_32_114_1
  doi: 10.1111/jdv.12080
– ident: e_1_2_32_66_1
  doi: 10.1001/archderm.1963.01590130018006
– volume: 75
  start-page: 150
  year: 1995
  ident: e_1_2_32_207_1
  article-title: The steroid‐sparing effect of long‐term plasmapheresis in pemphigus
  publication-title: Acta Derm Venereol
  doi: 10.2340/0001555575150152
– ident: e_1_2_32_76_1
  doi: 10.1046/j.1468-3083.2002.00413.x
– volume: 10
  start-page: 1
  year: 2007
  ident: e_1_2_32_73_1
  article-title: Pulse versus oral methylprednisolone therapy in pemphigus vulgaris
  publication-title: Arch Iran Med
– ident: e_1_2_32_74_1
  doi: 10.1016/j.det.2011.06.007
– ident: e_1_2_32_178_1
  doi: 10.1046/j.1365-2230.2000.00622.x
– ident: e_1_2_32_126_1
  doi: 10.7326/0003-4819-150-10-200905190-00004
– ident: e_1_2_32_84_1
  doi: 10.1007/s001980200108
– ident: e_1_2_32_124_1
  doi: 10.1001/jamadermatol.2014.1939
– ident: e_1_2_32_150_1
  doi: 10.1111/j.1365-4362.1995.tb04430.x
– ident: e_1_2_32_47_1
  doi: 10.1046/j.1365-2133.2002.04838.x
– ident: e_1_2_32_264_1
  doi: 10.1159/000287254
– ident: e_1_2_32_225_1
  doi: 10.1002/jca.21268
– ident: e_1_2_32_18_1
  doi: 10.1001/archderm.136.12.1569
– ident: e_1_2_32_71_1
  doi: 10.1111/j.1610-0378.2005.04747.x
– volume: 11
  start-page: 4
  year: 2005
  ident: e_1_2_32_82_1
  article-title: Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study
  publication-title: Dermatol Online J
  doi: 10.5070/D36NS4V35J
– ident: e_1_2_32_285_1
  doi: 10.1111/j.1365-4632.2006.02916.x
– ident: e_1_2_32_99_1
  doi: 10.1001/archderm.139.6.739
– ident: e_1_2_32_90_1
  doi: 10.1007/BF00498776
– ident: e_1_2_32_125_1
  doi: 10.1201/b18491-17
– volume: 9
  start-page: 2
  year: 2003
  ident: e_1_2_32_142_1
  article-title: Dexamethasone‐cyclophosphamide pulse therapy for autoimmune‐vesiculobullous disorders at Victoria hospital, Bangalore
  publication-title: Dermatol Online J
  doi: 10.5070/D35JR0R66P
– ident: e_1_2_32_85_1
  doi: 10.1001/archderm.1996.03890360091015
– ident: e_1_2_32_236_1
  doi: 10.1111/j.1468-3083.2006.01873.x
– ident: e_1_2_32_38_1
  doi: 10.1046/j.1365-2133.2001.04132.x
– volume: 62
  start-page: 647
  year: 1989
  ident: e_1_2_32_218_1
  article-title: Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris – preliminary report
  publication-title: Yale J Biol Med
– ident: e_1_2_32_280_1
  doi: 10.1159/000247795
– volume: 8
  start-page: 9
  year: 2009
  ident: e_1_2_32_246_1
  article-title: Demystifying the management of pemphigus
  publication-title: Dermatol Nurs
– volume: 17
  start-page: 4
  year: 2007
  ident: e_1_2_32_32_1
  article-title: Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus
  publication-title: Eur J Dermatol
– ident: e_1_2_32_40_1
  doi: 10.4103/0378-6323.25780
– ident: e_1_2_32_151_1
  doi: 10.1046/j.1365-2133.2001.04524.x
– ident: e_1_2_32_230_1
  doi: 10.1111/j.1365-2230.1995.tb01327.x
– ident: e_1_2_32_235_1
  doi: 10.1111/j.1529-8019.2010.01329.x
– volume: 69
  start-page: 334
  year: 2003
  ident: e_1_2_32_141_1
  article-title: Treatment of pemphigus with intravenous pulse cyclophosphamide
  publication-title: Indian J Dermatol Venereol Leprol
– ident: e_1_2_32_8_1
  doi: 10.1111/1523-1747.ep12337524
– ident: e_1_2_32_117_1
  doi: 10.1001/jamadermatol.2014.3674
– volume: 15
  start-page: 42
  year: 2012
  ident: e_1_2_32_239_1
  article-title: Randomized trial of tacrolimus 0·1% ointment versus triamcinolone acetonide 0·1% paste in the treatment of oral pemphigus vulgaris
  publication-title: Iran J Dermatol
– volume: 63
  start-page: 279
  year: 2011
  ident: e_1_2_32_161_1
  article-title: Management of pemphigus in pediatric patients
  publication-title: Minerva Pediatr
– ident: e_1_2_32_25_1
  doi: 10.1111/j.1440-0960.2005.00191.x
– ident: e_1_2_32_34_1
  doi: 10.1016/j.clindermatol.2011.03.017
– ident: e_1_2_32_72_1
  doi: 10.1001/archderm.142.11.1447
– volume: 7
  start-page: 195
  year: 1988
  ident: e_1_2_32_213_1
  article-title: Plasmapheresis therapy of pemphigus and bullous pemphigoid
  publication-title: Semin Dermatol
– volume: 124
  start-page: 1716
  year: 1988
  ident: e_1_2_32_214_1
  article-title: Plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris: a novelty or a reappraisal?
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1988.01670110072018
– ident: e_1_2_32_157_1
  doi: 10.1111/j.1365-2133.2009.09034.x
– volume: 104
  start-page: 14
  year: 1971
  ident: e_1_2_32_15_1
  article-title: Pemphigus. A 20‐year survey of experience with 70 cases
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1971.04000190016003
– ident: e_1_2_32_135_1
  doi: 10.1067/S0190-9622(03)00859-4
– ident: e_1_2_32_167_1
  doi: 10.1080/08916930600972008
– volume: 22
  start-page: 21
  issue: 2
  year: 2016
  ident: e_1_2_32_36_1
  article-title: An Oral Disease Severity Score (ODSS) validated for pemphigus vulgaris
  publication-title: Oral Dis
– ident: e_1_2_32_182_1
  doi: 10.1046/j.1365-4362.1999.00624.x
– ident: e_1_2_32_111_1
  doi: 10.1007/s00403-013-1355-4
– ident: e_1_2_32_95_1
  doi: 10.2165/00128071-200708020-00004
– ident: e_1_2_32_196_1
  doi: 10.1001/archderm.136.7.868
– ident: e_1_2_32_198_1
  doi: 10.1111/j.1365-2133.1978.tb01631.x
– ident: e_1_2_32_279_1
  doi: 10.1097/00000372-199708000-00017
– ident: e_1_2_32_22_1
  doi: 10.1016/S0190-9622(79)80050-X
– ident: e_1_2_32_52_1
  doi: 10.1111/j.1468-3083.2010.03584.x
– ident: e_1_2_32_107_1
  doi: 10.1016/j.jaad.2010.06.033
– ident: e_1_2_32_227_1
  doi: 10.1046/j.1365-2133.2003.05513.x
– ident: e_1_2_32_108_1
  doi: 10.1111/j.1365-2133.2011.10411.x
– volume: 69
  start-page: 97
  year: 2003
  ident: e_1_2_32_140_1
  article-title: Dexamethasone cyclophosphamide pulse therapy in pemphigus: experience in Kashmir valley
  publication-title: Indian J Dermatol Venereol Leprol
– ident: e_1_2_32_58_1
  doi: 10.1016/j.jaad.2013.05.016
– ident: e_1_2_32_183_1
  doi: 10.1111/j.1440-0960.1996.tb01013.x
– ident: e_1_2_32_219_1
  doi: 10.7326/0003-4819-112-4-303
– ident: e_1_2_32_81_1
  doi: 10.1111/jdv.12772
– ident: e_1_2_32_88_1
  doi: 10.1034/j.1600-0714.2002.00085.x
– ident: e_1_2_32_172_1
  doi: 10.1111/bjd.12474
– ident: e_1_2_32_5_1
  doi: 10.1111/1523-1747.ep12665364
– ident: e_1_2_32_179_1
  doi: 10.1001/archderm.141.6.699
– ident: e_1_2_32_208_1
  doi: 10.1067/mjd.2000.109297
– ident: e_1_2_32_133_1
  doi: 10.1111/j.1346-8138.1979.tb01927.x
– ident: e_1_2_32_143_1
  doi: 10.4103/0378-6323.31902
– ident: e_1_2_32_188_1
  doi: 10.1111/j.1468-3083.1995.tb00109.x
– ident: e_1_2_32_289_1
  doi: 10.1111/1346-8138.12486
– ident: e_1_2_32_249_1
  doi: 10.1034/j.1600-0536.2001.044004229.x
– ident: e_1_2_32_29_1
  doi: 10.1111/bjd.12198
– ident: e_1_2_32_10_1
  doi: 10.1001/archderm.1996.03890260105016
– ident: e_1_2_32_61_1
  doi: 10.1111/j.1468-3083.2010.03753.x
– ident: e_1_2_32_65_1
  doi: 10.1016/S0190-9622(08)81506-X
– ident: e_1_2_32_195_1
  doi: 10.2165/11586680-000000000-00000
– volume: 106
  start-page: 657
  year: 1972
  ident: e_1_2_32_130_1
  article-title: Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1972.01620140005001
– ident: e_1_2_32_237_1
  doi: 10.1111/j.1601-0825.2008.01445.x
– volume: 21
  start-page: 58
  year: 2011
  ident: e_1_2_32_158_1
  article-title: Catabolism of pemphigus foliaceus autoantibodies by high‐dose IVIg therapy
  publication-title: Eur J Dermatol
  doi: 10.1684/ejd.2011.1169
– ident: e_1_2_32_253_1
  doi: 10.1136/adc.88.2.96
– ident: e_1_2_32_284_1
  doi: 10.1016/S0190-9622(94)70060-5
– ident: e_1_2_32_55_1
  doi: 10.1038/jid.2010.91
– ident: e_1_2_32_11_1
  doi: 10.1111/j.1468-3083.1995.tb00306.x
– ident: e_1_2_32_177_1
  doi: 10.1111/j.1525-1470.1998.tb01370.x
– ident: e_1_2_32_2_1
  doi: 10.1111/j.1365-2133.2008.09026.x
– ident: e_1_2_32_118_1
  doi: 10.1056/NEJMoa062930
– ident: e_1_2_32_251_1
– ident: e_1_2_32_43_1
  doi: 10.1111/j.1468-3083.2011.04294.x
– ident: e_1_2_32_258_1
  doi: 10.1097/OGX.0b013e3181bea089
– ident: e_1_2_32_100_1
  doi: 10.1046/j.1365-2133.2003.05269.x
– ident: e_1_2_32_146_1
  doi: 10.1111/j.1365-2230.2009.03450.x
– volume: 120
  start-page: 44
  year: 1984
  ident: e_1_2_32_63_1
  article-title: Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1984.01650370050009
– ident: e_1_2_32_155_1
  doi: 10.2165/11533290-000000000-00000
– ident: e_1_2_32_154_1
  doi: 10.1111/j.1365-2249.2005.02834.x
– volume: 112
  start-page: 185
  year: 1976
  ident: e_1_2_32_189_1
  article-title: Management of pemphigus with gold compounds: a long‐term follow‐up report
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1976.01630260013004
– ident: e_1_2_32_104_1
  doi: 10.1016/j.autrev.2014.12.002
– volume: 132
  start-page: 1435
  year: 1996
  ident: e_1_2_32_87_1
  article-title: Treatment of pemphigus vulgaris with brief, high‐dose intravenous glucocorticoids
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1996.03890360021005
– ident: e_1_2_32_46_1
  doi: 10.1016/S0140-6736(17)30070-3
– ident: e_1_2_32_170_1
  doi: 10.1001/archderm.135.10.1275
– volume: 22
  start-page: 83
  year: 2012
  ident: e_1_2_32_171_1
  article-title: Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris
  publication-title: Eur J Dermatol
  doi: 10.1684/ejd.2011.1611
– ident: e_1_2_32_23_1
  doi: 10.1046/j.1365-2133.1999.02752.x
– ident: e_1_2_32_121_1
  doi: 10.1111/j.1365-2133.2011.10585.x
– volume: 68
  start-page: 413
  year: 1988
  ident: e_1_2_32_169_1
  article-title: Mucous membrane manifestations of pemphigus vulgaris. A 25‐year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin
  publication-title: Acta Derm Venereol
– ident: e_1_2_32_267_1
– volume: 110
  start-page: 862
  year: 1974
  ident: e_1_2_32_17_1
  article-title: Pemphigus. Epidemiologic and survival characteristics of 59 patients, 1955–1973
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1974.01630120012002
– ident: e_1_2_32_13_1
  doi: 10.1111/j.1365-4632.2004.02501.x
– volume: 58
  start-page: 171
  year: 1975
  ident: e_1_2_32_165_1
  article-title: Pemphigus: combined treatment with methotrexate and prednisone
  publication-title: J Med Assoc Thai
– ident: e_1_2_32_261_1
  doi: 10.1046/j.1365-2133.2000.03686.x
– ident: e_1_2_32_152_1
  doi: 10.3109/08916934.2011.606452
– ident: e_1_2_32_184_1
  doi: 10.1001/archderm.136.9.1133
– ident: e_1_2_32_4_1
  doi: 10.1172/JCI117349
– ident: e_1_2_32_56_1
  doi: 10.1016/j.jaad.2015.04.038
– ident: e_1_2_32_232_1
  doi: 10.1111/j.1365-2230.2004.01499.x
– volume: 21
  start-page: 696
  year: 2011
  ident: e_1_2_32_278_1
  article-title: Analysis of 6 cases of drug‐induced pemphigus
  publication-title: Eur J Dermatol
  doi: 10.1684/ejd.2011.1428
– volume: 11
  start-page: S1
  year: 2012
  ident: e_1_2_32_250_1
  article-title: Best practice in emollient therapy – a statement for healthcare professionals
  publication-title: Dermatol Nurs
– volume: 133
  start-page: 287
  year: 1997
  ident: e_1_2_32_221_1
  article-title: Severe pemphigus foliaceus treated with extracorporeal photochemotherapy
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1997.03890390021002
– ident: e_1_2_32_60_1
  doi: 10.1016/S0190-9622(96)80066-1
– ident: e_1_2_32_185_1
  doi: 10.1111/j.1365-2133.2009.09208.x
– ident: e_1_2_32_51_1
  doi: 10.1001/archderm.144.5.682
– ident: e_1_2_32_91_1
  doi: 10.1159/000251868
– volume: 124
  start-page: 1702
  year: 1988
  ident: e_1_2_32_211_1
  article-title: Plasmapheresis therapy of pemphigus
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1988.01670110062013
– volume: 1
  start-page: CD006263
  year: 2009
  ident: e_1_2_32_53_1
  article-title: Interventions for pemphigus vulgaris and pemphigus foliaceus
  publication-title: Cochrane Database Syst Rev
– ident: e_1_2_32_78_1
  doi: 10.1001/archderm.144.1.25
– ident: e_1_2_32_77_1
  doi: 10.1001/archderm.142.5.570
– ident: e_1_2_32_193_1
  doi: 10.1016/S0190-9622(88)70132-2
– ident: e_1_2_32_290_1
– ident: e_1_2_32_269_1
  doi: 10.2165/11310380-000000000-00000
– ident: e_1_2_32_220_1
  doi: 10.1016/S0190-9622(08)80854-7
– volume: 47
  start-page: 183
  year: 1998
  ident: e_1_2_32_241_1
  article-title: [Topical cyclosporine in the treatment of oral pemphigus]
  publication-title: Minerva Stomatol
– volume: 99
  start-page: 61
  year: 2003
  ident: e_1_2_32_252_1
  article-title: Should potassium permanganate be used in wound care?
  publication-title: Nurs Times
– ident: e_1_2_32_277_1
  doi: 10.1111/j.1473-2130.2004.00098.x
– volume: 9
  start-page: 684
  year: 2010
  ident: e_1_2_32_233_1
  article-title: Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double‐blind, placebo‐controlled clinical trial
  publication-title: J Drugs Dermatol
– ident: e_1_2_32_262_1
  doi: 10.1016/j.jaad.2014.05.071
– ident: e_1_2_32_288_1
  doi: 10.1016/j.det.2011.07.001
– ident: e_1_2_32_148_1
  doi: 10.2165/11311150-000000000-00000
– ident: e_1_2_32_21_1
  doi: 10.1001/archderm.1979.04010040006002
– ident: e_1_2_32_57_1
  doi: 10.1016/S0190-9622(00)90213-5
– volume: 13
  start-page: 142
  year: 2003
  ident: e_1_2_32_240_1
  article-title: Topical tacrolimus: a novel therapeutic intervention for recalcitrant labial pemphigus vulgaris
  publication-title: Eur J Dermatol
– ident: e_1_2_32_268_1
  doi: 10.1111/j.1525-1470.2011.01514.x
– ident: e_1_2_32_37_1
  doi: 10.1046/j.1365-2133.2000.03538.x
– ident: e_1_2_32_112_1
  doi: 10.1111/jdv.12678
– ident: e_1_2_32_274_1
  doi: 10.1111/j.1525-1470.2008.00808.x
– volume: 107
  start-page: 353
  year: 1973
  ident: e_1_2_32_94_1
  article-title: Pemphigus treatment with azathioprine. Clinical and immunologic correlation
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1973.01620180007002
– ident: e_1_2_32_287_1
  doi: 10.1111/j.1468-3083.2008.02948.x
– volume: 108
  start-page: 56
  year: 1973
  ident: e_1_2_32_187_1
  article-title: Gold sodium thiomalate treatment of pemphigus
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1973.01620220028007
– ident: e_1_2_32_123_1
  doi: 10.1016/j.jaad.2015.11.008
– ident: e_1_2_32_276_1
  doi: 10.1309/3CAKPEU8JXGWLEDC
– ident: e_1_2_32_31_1
– ident: e_1_2_32_190_1
  doi: 10.1001/archderm.134.9.1104
– ident: e_1_2_32_256_1
– volume: 115
  start-page: 728
  year: 1979
  ident: e_1_2_32_200_1
  article-title: Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1979.04010060036025
– ident: e_1_2_32_229_1
  doi: 10.1111/j.1744-9987.2012.01075.x
– ident: e_1_2_32_59_1
  doi: 10.1111/ced.12073
– ident: e_1_2_32_122_1
  doi: 10.1016/j.jaad.2011.11.007
– ident: e_1_2_32_134_1
  doi: 10.1016/S0190-9622(87)70226-6
– ident: e_1_2_32_209_1
  doi: 10.1111/j.1468-3083.2010.03703.x
– ident: e_1_2_32_3_1
  doi: 10.1503/cmaj.090449
– ident: e_1_2_32_70_1
  doi: 10.1016/S0190-9622(03)02738-5
– ident: e_1_2_32_101_1
  doi: 10.1016/j.jaad.2010.02.052
– ident: e_1_2_32_12_1
  doi: 10.1111/j.1365-2133.1995.tb02497.x
– volume: 106
  start-page: 491
  year: 1972
  ident: e_1_2_32_164_1
  article-title: Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1972.01620130023006
– ident: e_1_2_32_115_1
  doi: 10.1111/bjd.12972
– ident: e_1_2_32_113_1
  doi: 10.1111/j.1365-2133.2011.10663.x
– volume: 114
  start-page: 889
  year: 1978
  ident: e_1_2_32_131_1
  article-title: Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1978.01640180023005
– ident: e_1_2_32_265_1
  doi: 10.1093/rheumatology/ket409
– ident: e_1_2_32_106_1
  doi: 10.1056/NEJMoa067752
– ident: e_1_2_32_48_1
  doi: 10.1016/j.jaad.2008.01.012
– ident: e_1_2_32_41_1
  doi: 10.1111/j.1468-3083.2007.02254.x
– ident: e_1_2_32_156_1
  doi: 10.1016/j.jaad.2008.09.052
– ident: e_1_2_32_275_1
  doi: 10.1111/j.1346-8138.2011.01354.x
– ident: e_1_2_32_20_1
  doi: 10.1007/978-1-4899-7190-6_2
– volume-title: Dermatological Nursing: a Practical Guide
  year: 2000
  ident: e_1_2_32_247_1
– ident: e_1_2_32_7_1
  doi: 10.1371/journal.pone.0050696
– ident: e_1_2_32_14_1
  doi: 10.1111/j.1468-3083.2007.02537.x
– ident: e_1_2_32_19_1
  doi: 10.1111/j.1365-2230.1986.tb00423.x
– ident: e_1_2_32_132_1
  doi: 10.1111/j.1365-2133.1975.tb02251.x
– ident: e_1_2_32_98_1
  doi: 10.1016/S0190-9622(99)70203-3
– volume: 100
  start-page: 70
  year: 1969
  ident: e_1_2_32_162_1
  article-title: Treatment of pemphigus vulgaris with methotrexate
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1969.01610250076018
– ident: e_1_2_32_69_1
  doi: 10.1111/j.1346-8138.1978.tb01047.x
– ident: e_1_2_32_180_1
  doi: 10.1016/S0190-9622(08)80651-2
– ident: e_1_2_32_204_1
  doi: 10.1159/000249707
– ident: e_1_2_32_139_1
  doi: 10.1159/000057886
– volume: 80
  start-page: 335
  year: 2007
  ident: e_1_2_32_272_1
  article-title: Rituximab therapy in severe juvenile pemphigus vulgaris
  publication-title: Cutis
– ident: e_1_2_32_270_1
  doi: 10.1111/j.1365-2133.2005.06740.x
– ident: e_1_2_32_173_1
  doi: 10.1016/j.clindermatol.2011.03.014
– volume: 18
  start-page: 557
  year: 2008
  ident: e_1_2_32_215_1
  article-title: Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high‐dose immunoglobulin to prevent rebound increase in pathogenic IgG
  publication-title: Eur J Dermatol
– ident: e_1_2_32_163_1
  doi: 10.1111/j.1365-2133.1970.tb15707.x
– ident: e_1_2_32_62_1
  doi: 10.1111/j.1468-3083.2011.04170.x
– ident: e_1_2_32_102_1
  doi: 10.1038/jid.2008.192
– ident: e_1_2_32_282_1
  doi: 10.1016/j.jaad.2008.09.014
– ident: e_1_2_32_228_1
  doi: 10.1046/j.1365-2133.2003.05302.x
– ident: e_1_2_32_222_1
  doi: 10.1159/000018090
– ident: e_1_2_32_263_1
  doi: 10.1111/j.1525-1470.2007.00369.x
– ident: e_1_2_32_92_1
  doi: 10.1016/S0190-9622(87)70069-3
– ident: e_1_2_32_33_1
  doi: 10.1038/jid.2009.72
– ident: e_1_2_32_186_1
  doi: 10.1016/S0190-9622(00)90014-8
– volume: 125
  start-page: 843
  year: 1989
  ident: e_1_2_32_212_1
  article-title: Indications for future studies on the treatment of pemphigus with plasmapheresis
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1989.01670180115020
– ident: e_1_2_32_83_1
– ident: e_1_2_32_192_1
  doi: 10.1111/j.1365-4632.2008.03530.x
– volume: 112
  start-page: 962
  year: 1976
  ident: e_1_2_32_68_1
  article-title: Pemphigus: a 20‐year review of 107 patients treated with corticosteroids
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1976.01630310024005
– ident: e_1_2_32_245_1
  doi: 10.1111/j.1468-3083.2006.01587.x
– ident: e_1_2_32_27_1
  doi: 10.1111/bjd.14410
– ident: e_1_2_32_248_1
  doi: 10.1016/S0140-6736(99)00281-0
– ident: e_1_2_32_119_1
  doi: 10.1111/j.1365-2133.2011.10732.x
– ident: e_1_2_32_243_1
  doi: 10.1016/0190-9622(90)70352-I
– ident: e_1_2_32_242_1
  doi: 10.1016/S0190-9622(98)70476-1
– ident: e_1_2_32_234_1
  doi: 10.1111/j.1365-4632.2006.02766.x
– ident: e_1_2_32_93_1
  doi: 10.1136/bmj.3.5714.84
– ident: e_1_2_32_149_1
  doi: 10.1111/j.1346-8138.2003.tb00464.x
– ident: e_1_2_32_259_1
  doi: 10.1016/j.det.2011.06.008
– ident: e_1_2_32_6_1
  doi: 10.1046/j.1365-2133.2000.03660.x
– ident: e_1_2_32_153_1
  doi: 10.1385/CRIAI:29:3:289
– ident: e_1_2_32_80_1
  doi: 10.4103/0378-6323.55390
– volume: 18
  start-page: 20
  year: 2006
  ident: e_1_2_32_257_1
  article-title: Autoimmune bullous diseases: diagnosis and management
  publication-title: Dermatol Nurs
– ident: e_1_2_32_44_1
  doi: 10.1001/archdermatol.2009.9
– ident: e_1_2_32_96_1
  doi: 10.1111/j.1468-3083.2012.04717.x
– ident: e_1_2_32_49_1
  doi: 10.1016/j.jaad.2010.04.039
– ident: e_1_2_32_210_1
  doi: 10.1001/archderm.1988.01670110019004
– ident: e_1_2_32_266_1
  doi: 10.1016/0030-4220(94)90322-0
– ident: e_1_2_32_79_1
  doi: 10.1111/j.1468-3083.2007.02286.x
– ident: e_1_2_32_199_1
  doi: 10.1111/j.1365-2133.1979.tb05571.x
– ident: e_1_2_32_224_1
  doi: 10.1016/j.transci.2010.10.006
– ident: e_1_2_32_175_1
  doi: 10.1159/000250907
– ident: e_1_2_32_128_1
  doi: 10.1136/annrheumdis-2011-200477
– ident: e_1_2_32_147_1
  doi: 10.1111/j.1365-2133.2009.09590.x
– ident: e_1_2_32_174_1
  doi: 10.1111/j.1365-2133.1976.tb05168.x
– ident: e_1_2_32_231_1
  doi: 10.1111/j.1365-2230.1995.tb01301.x
– ident: e_1_2_32_144_1
  doi: 10.4103/0378-6323.53133
– ident: e_1_2_32_97_1
  doi: 10.1001/archderm.135.1.54
– ident: e_1_2_32_160_1
  doi: 10.1111/j.1468-3083.2010.03925.x
– ident: e_1_2_32_105_1
  doi: 10.2340/00015555-2116
– ident: e_1_2_32_45_1
  doi: 10.1111/j.1468-3083.2008.02715.x
– ident: e_1_2_32_110_1
  doi: 10.1016/j.jaad.2012.08.010
– ident: e_1_2_32_9_1
  doi: 10.1016/S0190-9622(99)70183-0
– ident: e_1_2_32_271_1
  doi: 10.1111/j.1525-1470.2005.00118.x
– ident: e_1_2_32_39_1
  doi: 10.1111/j.1365-4632.2006.02593.x
– ident: e_1_2_32_116_1
  doi: 10.1001/jamadermatol.2013.6739
– ident: e_1_2_32_226_1
  doi: 10.1111/j.1346-8138.1999.tb03463.x
– ident: e_1_2_32_145_1
  doi: 10.1080/09546630701449080
– ident: e_1_2_32_191_1
  doi: 10.1111/j.1468-3083.2006.02074.x
– ident: e_1_2_32_129_1
  doi: 10.1093/rheumatology/kem146a
– ident: e_1_2_32_16_1
  doi: 10.1046/j.1365-2133.1999.02612.x
– volume: 113
  start-page: 1236
  year: 1977
  ident: e_1_2_32_166_1
  article-title: Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1977.01640090084013
– ident: e_1_2_32_75_1
  doi: 10.1111/j.1365-4632.2010.04828.x
– volume: 123
  start-page: 1205
  year: 1987
  ident: e_1_2_32_205_1
  article-title: Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.1987.01660330116023
– ident: e_1_2_32_137_1
  doi: 10.4103/0378-6323.41366
– volume: 89
  start-page: 2057
  year: 1994
  ident: e_1_2_32_176_1
  article-title: Sulfone syndrome in a patient receiving steroids for pemphigus
  publication-title: Am J Gastroenterol
– ident: e_1_2_32_203_1
  doi: 10.1001/archderm.1983.01650270033013
– volume: 1
  start-page: 104
  year: 2005
  ident: e_1_2_32_254_1
  article-title: Evidence for atraumatic soft silicone wound dressing use
  publication-title: Wounds
– ident: e_1_2_32_281_1
  doi: 10.1111/j.1346-8138.2011.01382.x
– ident: e_1_2_32_28_1
  doi: 10.1111/j.1365-4362.1995.tb04450.x
– ident: e_1_2_32_159_1
  doi: 10.1080/08916930600972016
– ident: e_1_2_32_168_1
  doi: 10.1111/j.1365-2133.2009.09246.x
– ident: e_1_2_32_194_1
  doi: 10.1016/0190-9622(90)70277-O
– ident: e_1_2_32_283_1
  doi: 10.1111/j.1365-2133.1989.tb04165.x
– ident: e_1_2_32_286_1
  doi: 10.1016/j.jaad.2015.10.051
– ident: e_1_2_32_244_1
  doi: 10.1111/j.1468-3083.2010.03610.x
– ident: e_1_2_32_273_1
  doi: 10.1111/pde.12744
– ident: e_1_2_32_216_1
  doi: 10.1111/j.1744-9987.2009.00688.x
– ident: e_1_2_32_255_1
– ident: e_1_2_32_138_1
  doi: 10.1111/j.1365-4362.1990.tb04767.x
– ident: e_1_2_32_201_1
  doi: 10.1016/S0190-9622(81)70033-1
– start-page: 121
  year: 2002
  ident: e_1_2_32_260_1
  article-title: Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation
  publication-title: Clinical Transplants
– ident: e_1_2_32_50_1
  doi: 10.1016/j.jaad.2010.06.003
– ident: e_1_2_32_42_1
  doi: 10.1111/j.1600-0625.2010.01069.x
– ident: e_1_2_32_109_1
  doi: 10.1001/archdermatol.2011.3320
– ident: e_1_2_32_181_1
  doi: 10.1001/archderm.131.11.1339
– volume: 50
  start-page: 199
  year: 1984
  ident: e_1_2_32_136_1
  article-title: Pulse therapy with dexamethasone‐cyclophosphamide in pemphigus
  publication-title: Indian J Dermatol Venereol Leprol
– ident: e_1_2_32_30_1
  doi: 10.1186/1471-5945-4-10
– ident: e_1_2_32_223_1
  doi: 10.1111/j.1468-3083.2006.02044.x
– ident: e_1_2_32_67_1
  doi: 10.1038/jid.1969.166
– ident: e_1_2_32_238_1
  doi: 10.2334/josnusd.52.449
– ident: e_1_2_32_127_1
  doi: 10.1002/art.1780401213
– ident: e_1_2_32_120_1
  doi: 10.1111/jdv.12175
– ident: e_1_2_32_217_1
  doi: 10.1002/jca.20300
– ident: e_1_2_32_202_1
  doi: 10.1111/j.1365-2133.1982.tb00909.x
SSID ssj0013050
Score 2.567312
Snippet Plain language summary available online
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1170
SubjectTerms Administration, Cutaneous
Administration, Oral
Adrenal Cortex Hormones - administration & dosage
Aftercare
Autoimmune diseases
Blister - therapy
Chemotherapy, Adjuvant
Child
Clinical Laboratory Techniques - methods
Dermatologic Agents - therapeutic use
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Forecasting
Humans
Immunosorbent Techniques
Immunosuppressive Agents - therapeutic use
Infusions, Intravenous
Nursing Care
Pemphigus
Pemphigus - diagnosis
Pemphigus - therapy
Photopheresis - methods
Plasma Exchange - methods
Plasmapheresis - methods
Pregnancy
Pregnancy Complications - therapy
Refusal to Treat
Remission Induction
Skin diseases
Social Support
Title British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbjd.15930
https://www.ncbi.nlm.nih.gov/pubmed/29192996
https://www.proquest.com/docview/1970204648
https://www.proquest.com/docview/1971645359
Volume 177
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB4WD-LF92N9EcWDly7bpk1bPKmriKAHUfAglCSbiK_dxW49ePJv-Pf8Jc705foC8VZoQtrMTOabZOYLwFbXC2MrAuVEno4wQDHWQafgOSbiNubK-DakeueTU3F04R9fBpcN2KlqYQp-iHrDjSwjX6_JwKVKR4xc3XZb6Is5xesuF8Sb3znzPk4Q2kFRfkJbcahlJasQZfHUPT_7om8A8zNezR3O4RRcVZ9a5JnctbKhaunnLyyO__yXaZgsgSjbLTRnBhqmNwvjJ-VR-xzIku6IjQiQ9S3r0FKeX3qLCpK-vbyy64yosih9niECZogo2UOdVENdBgZV5uY6S9lTRpUjNylDQBDOw8Xhwfn-kVPex-Bo4ulzpKtEJKRBxGFcLj1EM12vzf1IWq2VdoUNImul9UJhEDca2fYxXNNxaKwrMWziCzDW6_fMEjAZIU4hgmTEExggciUs97X0Y93lvtJhE7YrySS6JCunOzPukypowSlL8ilrwmbddFAwdPzUaLUSb1IaaZq4cUilwcKPmrBRv0bzojMT2TP9LG-DAWXAg7gJi4Va1KN4McJjjBfxY3Ph_j58snfcyR-W_950BSZIFkXd4yqMDR8zs4YAaKjWc01_B7yqADU
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB5VQQIuLY9SthTqVhy4bJRde18SFyBUaUh6QImUS7WyHbtqKUlFshx66t_g7_FLmPE-SKGVqt5WWlve9czY33hmPgO8nYZJZuNI-WmoU3RQjPVxUwh9k3KbcWWETajeeXgU98aiP4kma_C-roUp-SGaAzeyDLdek4HTgfSKlauzaRs3Y44O-wOBQMMFab-Gf2MInagsQKHDONSzileI8niartd3o_8g5nXE6racgw04rj-2zDT51i6Wqq0v_-FxvO_fPIH1CouyD6XyPIU1M3sGD4dVtP05yIrxiK3IkM0t69Jq7u69RR1Z_L76xU4KYsuiDHqGIJghqGTfm7wa6nJhUGtOT4oF-1lQ8cjpgiEmSDZhfPB59KnnV1cy-Jqo-nwZqDiNpUHQYQIuQwQ007DDRSqt1koHsY1Sa6UNk9ggdDSyI9Bj01libCDRc-IvoDWbz8xLYDJFqEIcyQgp0EfkKrZcaCkyPeVC6cSDd7Vocl3xldO1Ged57bfglOVuyjzYb5pelCQdNzXaqeWbV3a6yIMsoergWKQe7DWv0cIobCJnZl64NuhTRjzKPNgq9aIZJcwQIaPLiB_rpHv78PnHftc9bN-96S486o2Gg3xwePTlFTwmuZRlkDvQWv4ozGvEQ0v1xqn9H8EZBFM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4hkFAv_LWUBVrcqodestrEjpOoJ8p2tdCCqqpIHCpFtmOvaGF3xW44cOpr8Ho8CTP5Y6EgVdwixZYTz4znG3vmM8CHLIgSJ0PtxYGJMUCxzkOnEHg25i7h2goXUb3z4ZHsH4uDk_BkDj7VtTAlP0Sz4UaWUazXZODjzM0Yuf6dtdEXc4zXF4RET0aI6Edwd4TQCcv6E9qLQzWraIUojafpet8Z_YMw7wPWwuP0luFX_a1losmfdj7VbXP1gMbxmT-zAksVEmW7peqswpwdrsHiYXXW_hJUxXfEZiTIRo51aS0vbr1FDZnc_L1mg5y4sih_niEEZggp2XmTVUNdxhZ15nSQT9hlTqUjpxOGiCB6Bce9Lz_3-l51IYNniKjPU76WsVQWIYf1uQoQzmRBh4tYOWO08aULY-eUCyJpETha1REYr5kkss5XGDfxdZgfjoZ2A5iKEagQQzICCowQuZaOC6NEYjIutIla8LGWTGoqtnK6NOMsraMWnLK0mLIWvG-ajkuKjscabdfiTSsrnaR-ElFtsBRxC941r9G-6NBEDe0oL9pgRBnyMGnB61ItmlGCBPExBoz4sYVwnx4-_XzQLR42_7_pDix-7_bSb_tHX7fgBYmlrIHchvnpRW7fIBia6reF0t8Cs2kDAg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=British+Association+of+Dermatologists%27+guidelines+for+the+management+of+pemphigus+vulgaris+2017&rft.jtitle=British+journal+of+dermatology+%281951%29&rft.au=Harman%2C+K+E&rft.au=Brown%2C+D&rft.au=Exton%2C+L+S&rft.au=Groves%2C+R+W&rft.date=2017-11-01&rft.eissn=1365-2133&rft.volume=177&rft.issue=5&rft.spage=1170&rft_id=info:doi/10.1111%2Fbjd.15930&rft_id=info%3Apmid%2F29192996&rft.externalDocID=29192996
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0963&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0963&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0963&client=summon